Other and unspecified urticaria

L12_URTICA_NAS

urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L50.8, L50.9 Hospital discharge: ICD-9 — 708[8-9] Hospital discharge: ICD-8 — 708 Cause of death: ICD-10 — L50.8, L50.9 Cause of death: ICD-9 — 708[8-9] Cause of death: ICD-8 — 708 2 out of 7 registries used, show all original rules.	8981
4. Check minimum number of events None	8981
5. Include endpoints None	8981
6. Filter based on genotype QC (FinnGen only)	8981

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	L12_URTICA_NAS
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L50[8-9]
HD_ICD_9	708[8-9]
HD_ICD_8	708
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L50[8-9]
COD_ICD_9	708[8-9]
COD_ICD_8	708
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	77117	45690	31011
Only index persons	66004	40315	25689
Unadjusted period prevalence (%)
Whole population	1.13	1.31	0.87
Only index persons	1.29	1.48	0.98
Median age at first event (years)
Whole population	28.20	33.41	20.39
Only index persons	30.53	35.04	23.44

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8981	6413	2568
Unadjusted period prevalence (%)	1.88	2.19	1.13
Median age at first event (years)	39.88	39.54	40.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8113: Matched controls
81130

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L50.9

ICD-10 Finland

Urticaria, unspecified

229.7

323.0

4718

488

H02AB06

ATC

prednisolone; systemic

3.6

323.0

4987

25098

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

+∞

323.0

448

XQ800

NOMESCO Finland

Prick test

7.4

323.0

1861

3153

R06AE07

ATC

cetirizine; oral

3.6

323.0

5124

26353

R06AE09

ATC

levocetirizine; oral

3.8

323.0

2148

7102

L50.3

ICD-10 Finland

Dermatographic urticaria

123.2

323.0

562

70890

ICD-8 Finland

Urticaria, Acuta

+∞

323.0

438

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

6.0

323.0

1935

4048

L50.8

ICD-10 Finland

Other urticaria

484.9

323.0

2596

T78.4

ICD-10 Finland

Allergy, unspecified

6.1

323.0

960

1746

R06AX27

ATC

desloratadine; oral

2.9

323.0

3362

15756

L50.0

ICD-10 Finland

Allergic urticaria

25.0

323.0

782

345

C01CA24

ATC

epinephrine; parenteral

7.9

323.0

1640

2520

70899

ICD-8 Finland

Urticaria, Other and unspecified

+∞

254.5

243

R03DC03

ATC

montelukast; oral

2.9

252.0

1893

7805

T78.3

ICD-10 Finland

Angioneurotic oedema

15.2

247.9

423

292

7089X

ICD-9 Finland

Urticaria, unspecified

+∞

228.2

218

L50.1

ICD-10 Finland

Idiopathic urticaria

59.4

219.0

259

R06AX22

ATC

ebastine; oral

2.5

200.4

1870

8596

H02AB07

ATC

prednisone; oral

2.8

189.0

1431

5807

L50

ICD-10 Finland

Urticaria

9.0

163.4

360

416

XQ802

NOMESCO Finland

Epicutan test

4.4

160.4

620

1483

E0000UV

ATC

1.9

152.1

3465

22941

R03AC02

ATC

salbutamol; inhalant

1.9

152.0

4468

32318

H02AB04

ATC

methylprednisolone; systemic

2.4

140.4

1346

6140

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

138.2

1607

8055

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

128.4

3103

20587

R06AX13

ATC

loratadine; oral

2.2

125.8

1565

8046

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

9.3

119.3

257

285

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

4.0

112.9

481

1252

A02BC02

ATC

pantoprazole; systemic

1.7

111.4

4858

37963

D07AC01

ATC

betamethasone; topical

1.8

108.2

2636

17274

J01AA02

ATC

doxycycline; systemic

1.7

106.7

5954

49675

70800

ICD-8 Finland

Urticaria, Angioneurotic oedema

+∞

106.5

102

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

105.6

1504

8119

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.7

104.4

783

3081

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

103.2

1586

8815

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

102.8

2966

20389

J01FA10

ATC

azithromycin; systemic

1.7

101.9

4938

39243

D07AB08

ATC

desonide; topical

2.4

101.6

986

4465

N02AX02

ATC

tramadol; systemic, rectal

1.7

99.1

3048

21286

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

97.9

2242

14301

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

94.3

881

3903

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

93.9

2059

12917

N05BB01

ATC

hydroxyzine; systemic

2.8

93.4

640

2376

7088A

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA CHRONICA NUD]

+∞

92.9

E000001

ATC

1.9

91.2

1757

10543

J01FF01

ATC

clindamycin; systemic

1.8

90.0

2098

13391

A02BA02

ATC

ranitidine; systemic

1.9

88.2

1431

8061

J01FA06

ATC

roxithromycin; oral

1.6

88.2

3120

22433

344

Kela drug reimbursment

Omalizumab

107.9

88.1

D07AC13

ATC

mometasone; topical

1.7

87.3

2236

14664

J01DB01

ATC

cefalexin; oral

1.7

85.4

6463

56409

D07AA02

ATC

hydrocortisone; topical

2.0

84.0

1246

6769

N02BE01

ATC

paracetamol; systemic, rectal

1.7

82.5

6614

58284

S98

ICPC

Urticaria

11.2

81.8

158

143

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

79.3

3428

25717

A92

ICPC

Allergy/allergic reaction NOS

3.7

78.9

370

1043

R01AD09

ATC

mometasone; nasal

1.6

77.9

3640

27793

R03BA02

ATC

budesonide; inhalant

1.9

77.8

1433

8403

7088B

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA RECURRENS NUD]

+∞

77.2

A02BC05

ATC

esomeprazole; systemic

1.6

77.1

2947

21396

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

76.5

3760

29011

R01AD08

ATC

fluticasone; nasal

1.6

75.8

2310

15789

R06AX26

ATC

fexofenadine; oral

2.4

74.5

662

2842

R06.0

ICD-10 Finland

Dyspnoea

1.7

74.3

1730

10929

M54.5

ICD-10 Finland

Low back pain

1.6

73.6

2522

17751

M25.5

ICD-10 Finland

Pain in joint

1.6

73.0

2227

15189

M03BX02

ATC

tizanidine; oral

1.5

73.0

4762

39045

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

72.7

1641

10257

J01FA09

ATC

clarithromycin; systemic

1.6

71.4

2533

17953

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

70.4

1420

8552

R51.80

ICD-10 Finland

Headache

1.8

69.6

1296

7596

7088X

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA ALIA DEFINITA]

+∞

68.8

R03BA05

ATC

fluticasone; inhalant

1.8

68.6

1497

9238

N03AX16

ATC

pregabalin; oral

1.7

68.2

1674

10705

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

67.1

1364

8223

L50.2

ICD-10 Finland

Urticaria due to cold and heat

44.1

67.1

XQ899

NOMESCO Finland

Other assessment of skin

16.2

66.6

109

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

66.1

1857

12325

L20.0

ICD-10 Finland

Besnier prurigo

2.2

66.0

696

3248

R03DX05

ATC

omalizumab; parenteral

92.1

66.0

XQ820

NOMESCO Finland

Exposure to medicinal substance

16.1

65.7

108

M79.6

ICD-10 Finland

Pain in limb

1.6

65.7

2624

19054

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

65.2

1264

7494

J01DA01

ATC

[U] cefalexin; systemic

1.5

63.3

4733

39356

J45

ICD-10 Finland

Asthma

2.1

63.1

809

4113

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

62.2

998

5535

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

60.9

1820

12240

J01MA02

ATC

ciprofloxacin; systemic

1.5

59.4

2575

18945

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

59.4

2739

20434

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

7.7

58.6

140

185

XQ801

NOMESCO Finland

Intracutantest

14.0

57.7

100

R01AD12

ATC

fluticasone furoate; nasal

1.5

56.7

2410

17607

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

56.7

993

5667

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

56.6

1288

7997

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

55.8

1445

9312

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.2

55.6

220

534

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

54.8

412

1607

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

54.2

1736

11827

A02BC03

ATC

lansoprazole; oral

1.6

54.0

1956

13734

XQ810

NOMESCO Finland

Physical test for urticaria

46.0

52.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

51.9

973

5670

A02BC01

ATC

omeprazole; systemic

1.6

51.7

1853

12958

R50.9

ICD-10 Finland

Fever, unspecified

1.8

51.2

1030

6139

J01MA12

ATC

levofloxacin; systemic

1.7

50.8

1166

7234

70898

ICD-8 Finland

Urticaria, Alia definita

+∞

50.0

P01AB01

ATC

metronidazole; oral, rectal

1.4

49.9

2915

22624

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

49.8

2233

16405

R03AC03

ATC

terbutaline; inhalant

1.7

49.4

1091

6688

J02AC01

ATC

fluconazole; systemic

1.4

49.4

3194

25274

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.2

49.0

531

2498

N03AX12

ATC

gabapentin; oral

1.7

48.2

1059

6475

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

47.8

1678

11641

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

47.0

1589

10918

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.2

47.0

150

292

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

46.5

601

3051

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.3

46.4

178

420

AA1AD

NOMESCO Finland

CT of head and brain

1.6

45.5

1404

9421

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

44.8

2051

15066

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

44.6

311

1158

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

44.2

1172

7553

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

44.1

355

1437

G44.2

ICD-10 Finland

Tension-type headache

1.7

43.9

1049

6562

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

43.8

713

3946

R60.0

ICD-10 Finland

Localized oedema

1.9

43.8

683

3724

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

43.7

3021

24024

X58

ICD-10 Finland

Exposure to other specified factors

1.7

43.6

997

6158

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

43.6

1337

8948

L50.5

ICD-10 Finland

Cholinergic urticaria

221.1

42.9

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.7

42.8

149

319

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

42.7

530

2643

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

42.6

2041

15105

C07AB07

ATC

bisoprolol; oral

1.4

42.4

2683

20967

D07AD01

ATC

clobetasol; topical

1.7

42.1

1052

6661

S29

ICPC

Skin symptom/complaint other

1.6

42.1

1134

7329

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

22.4

41.3

SPAT1263

SPAT

Sampling

1.4

41.3

3121

25145

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

40.9

667

3690

D02AE01

ATC

carbamide; topical

2.1

40.5

511

2566

R42

ICD-10 Finland

Dizziness and giddiness

1.6

40.4

1365

9332

R96

ICPC

Asthma

1.9

40.4

619

3346

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

40.4

681

3814

UJF32

NOMESCO Finland

Coloscopy

1.5

40.3

1560

11008

S88

ICPC

Dermatitis contact/allergic

3.5

40.2

198

582

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

40.1

1559

11008

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

+∞

39.6

R06AX18

ATC

acrivastine; oral

2.9

39.5

253

896

R05

ICPC

Cough

1.5

39.4

1614

11524

L03

ICPC

Low back symptom/complaint

1.5

39.3

1706

12332

E000002

ATC

1.7

39.3

888

5454

R03BA08

ATC

ciclesonide; inhalant

1.9

39.1

620

3395

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

38.8

697

3988

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

38.7

1518

10734

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

38.3

417

1962

R03BA01

ATC

beclometasone; inhalant

1.7

38.1

965

6123

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

37.9

1223

8258

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

37.5

2789

22291

J01FA01

ATC

erythromycin; systemic

1.6

37.5

1121

7425

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

37.5

760

4515

R01AD05

ATC

budesonide; nasal

1.9

36.6

583

3197

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

36.5

602

3339

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

36.5

1954

14703

R53

ICD-10 Finland

Malaise and fatigue

1.5

36.3

1371

9594

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

36.3

2597

20589

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

36.2

1115

7438

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

36.1

5455

48753

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

36.0

600

3341

R02

ICPC

Shortness of breath/dyspnoea

1.7

35.8

775

4695

R21

ICPC

Throat symptom/complaint

1.5

35.6

1651

12061

N06AX21

ATC

duloxetine; oral

1.7

35.6

784

4774

M01AH05

ATC

etoricoxib; oral

1.3

35.3

4115

35241

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

35.1

1712

12634

M79.1

ICD-10 Finland

Myalgia

1.6

34.9

936

6018

R05

ICD-10 Finland

Cough

1.5

34.9

1317

9205

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

13.4

34.3

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

34.0

3597

30276

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

33.9

611

3491

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

33.4

663

3909

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

33.3

324

1449

N06AX16

ATC

venlafaxine; oral

1.6

33.2

1023

6813

D02AX

ATC

Other emollients and protectives

2.4

33.2

283

1182

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

33.1

505

2726

G47.3

ICD-10 Finland

Sleep apnoea

1.5

33.0

1268

8887

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

32.8

702

4232

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

32.7

1197

8300

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

32.6

289

1235

X57

ICD-10 Finland

Unspecified privation

3.1

32.5

183

596

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

32.2

673

4028

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.6

32.0

239

928

L15

ICPC

Knee symptom/complaint

1.5

31.8

1369

9820

L17

ICPC

Foot/toe symptom/complaint

1.4

31.7

1667

12444

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

31.7

197

686

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

31.6

4024

34661

R74

ICPC

Upper respiratory infection acute

1.4

31.6

2254

17761

M02AA07

ATC

piroxicam; topical

1.4

31.6

2269

17903

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

31.6

1841

14006

M01AE02

ATC

naproxen; oral, rectal

1.3

31.5

4200

36419

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

31.4

303

1349

E000007

ATC

1.9

31.3

453

2396

R03AC13

ATC

formoterol; inhalant

2.2

31.3

341

1606

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

31.0

553

3147

H03AA01

ATC

levothyroxine sodium; systemic

1.4

30.8

1596

11869

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

30.7

1774

13468

N06AX11

ATC

mirtazapine; oral

1.4

30.4

2132

16735

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

30.3

1589

11843

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

30.2

3784

32433

L12

ICPC

Hand/finger symptom/complaint

1.5

30.1

983

6628

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

30.1

451

2415

N05CF01

ATC

zopiclone; oral

1.4

30.1

1969

15270

L95.8

ICD-10 Finland

Other vasculitis limited to skin

13.0

30.0

J01FA15

ATC

telithromycin; oral

1.7

30.0

706

4376

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

29.6

916

6092

R03BB04

ATC

tiotropium bromide; inhalant

1.8

29.6

518

2929

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

29.5

871

5730

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

29.4

276

1210

M01AB05

ATC

diclofenac; systemic, rectal

1.3

29.4

4673

41343

L51.9

ICD-10 Finland

Erythema multiforme, unspecified

30.1

29.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

29.0

1024

7026

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

28.8

277

1231

Y0999

ICD-8 Finland

Other specific examinations and investigations

8.5

28.6

S18

ICPC

Laceration/cut

1.3

28.5

2608

21303

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

28.4

1418

10455

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

28.2

605

3645

L01

ICPC

Neck symptom/complaint

1.5

28.2

963

6555

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

28.2

939

6357

J01MA14

ATC

moxifloxacin; systemic

1.8

28.1

530

3070

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

27.7

424

2288

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

27.3

378

1966

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

27.3

737

4737

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

27.1

480

2725

WX110

NOMESCO Finland

Local anesthesy

1.3

27.1

5153

46454

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

27.0

723

4633

D01

ICPC

Abdominal pain/cramps general

1.6

27.0

808

5326

A01

ICPC

Pain general/multiple sites

1.8

26.9

501

2890

M79.7

ICD-10 Finland

Fibromyalgia

2.2

26.9

275

1259

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

26.8

919

6254

Z71.8

ICD-10 Finland

Other specified counselling

1.4

26.7

1676

12862

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

4.5

26.5

217

E000006

ATC

1.8

26.5

492

2835

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

26.4

359

1853

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.2

26.4

142

449

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

26.4

274

1262

R03AC12

ATC

salmeterol; inhalant

2.2

26.1

283

1331

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

26.0

1967

15553

R07.3

ICD-10 Finland

Other chest pain

1.7

25.8

567

3437

L04AD01

ATC

ciclosporin; systemic

3.0

25.8

152

513

A02BC04

ATC

rabeprazole; oral

1.7

25.8

563

3409

S02

ICPC

Pruritus

2.2

25.8

257

1164

P01BA02

ATC

hydroxychloroquine; oral

1.7

25.5

556

3365

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

25.4

833

5609

J05AB01

ATC

aciclovir; systemic

1.4

25.3

1407

10556

N05BA04

ATC

oxazepam; oral

1.4

25.2

1632

12567

UKC02

NOMESCO Finland

Cystoscopy

1.6

25.2

777

5154

L29.8

ICD-10 Finland

Other pruritus

3.8

25.2

107

281

J01DA06

ATC

[U] cefuroxime; systemic

1.5

25.1

968

6756

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

25.1

1746

13606

R11

ICD-10 Finland

Nausea and vomiting

1.7

25.0

531

3188

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

25.0

510

3026

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

25.0

1082

7738

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.7

25.0

606

3779

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

25.0

850

5773

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

24.9

447

2549

C09CA06

ATC

candesartan; oral

1.4

24.8

1287

9531

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

24.8

454

2607

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

24.8

1752

13687

J04BA02

ATC

dapsone; oral

6.4

24.6

102

R00.2

ICD-10 Finland

Palpitations

1.7

24.6

492

2902

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

24.3

2070

16630

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

24.3

1210

8890

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

24.1

534

3245

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

24.1

715

4702

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

24.1

1327

9932

ZX112

NOMESCO Finland

Subcutaneous

2.8

24.0

155

554

J02AC02

ATC

itraconazole; systemic

1.4

23.9

1179

8643

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

23.8

2271

18544

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

23.7

2056

16553

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

23.6

722

4780

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

23.6

461

2700

WZC30

NOMESCO Finland

Teaching

1.5

23.6

789

5335

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

23.5

280

1372

N05BA01

ATC

diazepam; systemic, rectal

1.5

23.5

818

5580

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

23.4

445

2585

R06.2

ICD-10 Finland

Wheezing

2.0

23.3

305

1551

J46

ICD-10 Finland

Status asthmaticus

2.4

23.3

201

848

N02AA05

ATC

oxycodone; systemic

1.6

23.3

709

4686

Z01.2

ICD-10 Finland

Dental examination

1.3

23.3

3022

25705

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.8

23.3

100

266

C07AA05

ATC

propranolol; systemic

1.4

23.2

1343

10128

C03CA01

ATC

furosemide; systemic

1.4

23.2

1281

9584

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

23.1

2316

19020

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

23.1

539

3325

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

23.1

759

5110

SPAT1254

SPAT

Administration of medicine

1.5

23.0

926

6515

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

22.9

651

4232

L08

ICPC

Shoulder symptom/complaint

1.4

22.9

1129

8268

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

22.8

427

2470

H57.1

ICD-10 Finland

Ocular pain

2.2

22.8

241

1121

H02AB09

ATC

hydrocortisone; systemic

2.5

22.7

182

740

D11

ICPC

Diarrhoea

1.5

22.6

793

5419

A01AB09

ATC

miconazole; local oral

1.6

22.5

551

3447

N05AH04

ATC

quetiapine; oral

1.4

22.5

1122

8237

M01AH02

ATC

rofecoxib; oral

1.5

22.3

731

4918

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

22.2

391

2216

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.8

22.2

405

2320

N06AB04

ATC

citalopram; systemic

1.4

22.1

1386

10589

S06.0

ICD-10 Finland

Concussion

1.6

22.1

673

4450

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

22.0

739

4996

R05FB02

ATC

cough suppressants and expectorants

1.3

22.0

2343

19380

J05AB11

ATC

valaciclovir; oral

1.5

21.9

841

5856

R01AD01

ATC

beclometasone; nasal

1.4

21.9

1016

7350

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

21.8

716

4819

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

21.8

346

1896

J01EA01

ATC

trimethoprim; systemic

1.3

21.7

1689

13349

SPAT1260

SPAT

Consultation of another employee

1.4

21.7

1140

8443

J20

ICD-10 Finland

Acute bronchitis

1.6

21.7

605

3916

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

21.6

1401

10757

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

21.6

817

5670

N30.0

ICD-10 Finland

Acute cystitis

1.5

21.5

919

6539

L27.2

ICD-10 Finland

Dermatitis due to ingested food

3.3

21.5

110

337

SPAT1211

SPAT

Application of soft bandage

1.6

21.5

583

3743

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

21.5

1021

7419

A03

ICPC

Fever

1.4

21.4

1200

8989

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

21.3

279

1421

Z00.0

ICD-10 Finland

General medical examination

1.4

21.3

1182

8838

A04

ICPC

Weakness/tiredness general

1.5

21.2

832

5817

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

21.2

787

5442

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

21.2

513

3199

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

21.1

350

1945

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

21.1

239

1149

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.7

21.0

155

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

7.6

21.0

J01MA06

ATC

norfloxacin; oral

1.5

20.8

833

5850

R06.4

ICD-10 Finland

Hyperventilation

2.7

20.8

142

529

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

20.7

178

750

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

20.6

560

3596

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

20.6

672

4512

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

20.6

724

4944

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

20.6

646

4300

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.3

20.5

187

814

N03AX09

ATC

lamotrigine; oral

1.8

20.5

350

1963

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

20.5

533

3385

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

20.4

1063

7854

SPAT1312

SPAT

General health counselling

1.3

20.4

2275

18893

N01

ICPC

Headache

1.5

20.4

806

5648

UDM02

NOMESCO Finland

Sinoscopy

2.5

20.3

163

662

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

20.3

616

4063

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

20.3

335

1857

C08CA01

ATC

amlodipine; oral

1.3

20.3

1768

14193

B02AA02

ATC

tranexamic acid; systemic

1.4

20.2

1008

7386

R52.9

ICD-10 Finland

Pain, unspecified

1.6

20.2

527

3348

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.4

20.1

100

301

K30

ICD-10 Finland

Functional dyspepsia

1.5

20.1

661

4449

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

20.0

710

4857

K02.1

ICD-10 Finland

Caries of dentine

1.2

20.0

4185

37435

SPAT1310

SPAT

Counselling related to known health issue

1.3

19.9

2153

17799

WX002

NOMESCO Finland

Sedation and analgesia

1.4

19.8

1120

8393

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

19.8

407

2422

W84

ICD-10 Finland

Unspecified threat to breathing

7.8

19.7

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

19.6

370

2145

R13

ICD-10 Finland

Dysphagia

1.8

19.5

345

1958

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

19.5

436

2660

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.1

19.4

105

337

A07AA02

ATC

nystatin; oral

1.8

19.2

359

2072

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

19.2

235

1167

SPAT1153

SPAT

Removal of sutures

1.3

19.2

1873

15255

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

19.1

419

2541

N06AA09

ATC

amitriptyline; systemic

1.6

19.1

583

3854

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

19.1

920

6695

S21

ICPC

Skin texture symptom/complaint

1.5

19.1

735

5118

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

19.0

496

3153

SPAT1058

SPAT

PEF monitoring instruction

1.6

19.0

483

3052

J45.8

ICD-10 Finland

Mixed asthma

2.1

19.0

212

1014

N05CF02

ATC

zolpidem; oral

1.4

18.9

1130

8543

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

18.9

809

5759

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

18.8

678

4654

W19

ICD-10 Finland

Unspecified fall

1.6

18.8

557

3656

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

18.8

4897

44733

134

Kela drug reimbursment

General erythroderma

+∞

18.8

M01AC06

ATC

meloxicam; systemic, rectal

1.3

18.7

2259

18902

J32.4

ICD-10 Finland

Chronic pansinusitis

3.0

18.7

110

374

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

18.6

3824

34013

C08CA05

ATC

nifedipine; systemic

1.8

18.6

339

1946

Z51.6

ICD-10 Finland

Desensitization to allergens

2.9

18.6

114

398

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

18.5

1068

8024

R75

ICPC

Sinusitis acute/chronic

1.8

18.4

319

1800

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

18.4

670

4608

SPAT1301

SPAT

No procedures

1.3

18.4

2028

16771

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.9

18.3

109

373

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

18.3

857

6204

C07AB02

ATC

metoprolol; systemic

1.4

18.2

988

7344

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

18.2

396

2397

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

18.1

278

1504

M01AX17

ATC

nimesulide; oral

1.3

18.1

1367

10720

J01DA08

ATC

[U] cefaclor; oral

1.4

17.7

851

6185

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

17.7

415

2565

3DX05

NOMESCO Finland

66.7

17.7

R52.2

ICD-10 Finland

Other chronic pain

2.1

17.7

207

1011

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

17.6

159

690

L53.9

ICD-10 Finland

Erythematous condition, unspecified

4.2

17.5

162

K07.60

ICD-10 Finland

Snapping jaw

1.7

17.4

355

2108

H01

ICPC

Ear pain/earache

1.4

17.4

754

5374

R03DA04

ATC

theophylline; systemic, rectal

1.9

17.4

256

1366

L04AX01

ATC

azathioprine; systemic

1.8

17.3

291

1625

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

17.3

2865

24816

WX290

NOMESCO Finland

Other blockade of nerve

1.2

17.3

3265

28688

S01

ICPC

Pain/tenderness of skin

1.9

17.3

264

1427

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.7

17.3

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

17.3

4121

37122

R4110

NOMESCO Finland

Physiotherapy

1.3

17.2

1601

12925

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

17.2

3745

33409

C01DA14

ATC

isosorbide mononitrate; oral

1.5

17.2

567

3814

SPAT1283

SPAT

Restricted health certificate

1.3

17.1

1416

11245

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

17.0

328

1917

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

16.9

420

2635

XQ848

NOMESCO Finland

Dermatological photography

2.3

16.9

151

654

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

16.8

452

2893

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

16.8

509

3359

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

16.8

2615

22483

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

16.8

637

4421

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.6

16.7

484

3159

L16

ICPC

Ankle symptom/complaint

1.5

16.6

662

4641

J01MA01

ATC

ofloxacin; systemic

1.6

16.5

441

2817

R01AD11

ATC

triamcinolone; nasal

1.5

16.5

562

3806

A03FA02

ATC

cisapride; oral, rectal

1.6

16.5

420

2652

ZXA10

NOMESCO Finland

Bilateral

1.4

16.5

1059

8090

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

16.5

865

6385

A99

ICPC

Disease/condition unspecnature/site

1.6

16.5

459

2967

M01AB55

ATC

diclofenac, combinations; oral

1.7

16.4

362

2198

WZA90

NOMESCO Finland

Other doctors statement

1.3

16.4

1537

12410

J01CA04

ATC

amoxicillin; systemic

1.3

16.3

6181

58290

TAB00

NOMESCO Finland

Lumbar puncture

1.8

16.3

289

1642

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

16.3

734

5271

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

16.3

235

1246

M54

ICD-10 Finland

Dorsalgia

1.4

16.3

706

5033

R55

ICD-10 Finland

Syncope and collapse

1.5

16.3

547

3695

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

16.2

309

1799

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

16.2

458

2969

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

16.2

705

5029

L30.3

ICD-10 Finland

Infective dermatitis

2.0

16.2

200

998

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

16.1

200

1002

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

16.7

16.0

A02BA04

ATC

nizatidine; systemic

1.6

16.0

404

2547

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.4

16.0

133

555

R03BC03

ATC

nedocromil; inhalant

1.6

16.0

432

2772

D09AB01

ATC

zinc bandage without supplements; topical

2.6

16.0

116

450

B01AB05

ATC

enoxaparin; parenteral

1.3

16.0

1705

13998

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

15.9

263

1463

L13

ICPC

Hip symptom/complaint

1.4

15.8

852

6317

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

15.8

146

640

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.2

15.8

157

714

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

15.8

376

2333

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.4

15.8

134

563

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

15.8

336

2023

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

5.5

15.8

A12

ICPC

ALLERGY/ALLERGIC REACTION

5.2

15.7

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

15.6

752

5466

M54.2

ICD-10 Finland

Cervicalgia

1.6

15.6

431

2783

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

15.6

225

1192

D06

ICPC

Abdominal pain localized other

1.5

15.5

530

3594

104

Kela drug reimbursment

Thyroid insufficiency

1.6

15.5

430

2780

N17

ICPC

Vertigo/dizziness

1.5

15.5

618

4333

K08.80

ICD-10 Finland

Toothache NOS

1.5

15.4

530

3596

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

15.3

162

760

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

15.3

527

3580

N06AB10

ATC

escitalopram; oral

1.3

15.3

1392

11182

D11AH01

ATC

tacrolimus; topical

3.1

15.2

259

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

15.2

175

852

J01

ICD-10 Finland

Acute sinusitis

1.7

15.2

323

1945

S06

ICPC

Rash localized

1.7

15.1

329

1992

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

15.1

405

2597

R51.81

ICD-10 Finland

Facial pain NOS

2.2

15.0

149

678

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

14.9

540

3705

XQ817

NOMESCO Finland

9.4

14.9

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.7

14.8

174

R09

ICPC

Sinus symptom/complaint

1.5

14.8

525

3593

L04AA01

ATC

[U] ciclosporin; systemic

2.7

14.7

100

373

A46

ICD-10 Finland

Erysipelas

1.4

14.7

662

4746

H92.0

ICD-10 Finland

Otalgia

1.7

14.7

340

2093

B01AC04

ATC

clopidogrel; oral

1.4

14.7

633

4505

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

14.7

247

1381

M35.7

ICD-10 Finland

Hypermobility syndrome

2.5

14.7

115

466

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

14.7

224

1215

L14

ICPC

Leg/thigh symptom/complaint

1.6

14.6

403

2601

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

14.6

342

2113

XF402

NOMESCO Finland

ECG with work load test

1.5

14.5

546

3780

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

14.4

132

580

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

14.4

290

1718

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

14.4

525

3612

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

14.4

817

6112

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

14.3

1660

13744

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

14.3

175

874

D09

ICPC

Nausea

1.7

14.2

315

1919

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

14.2

583

4111

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

14.2

245

1386

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

14.2

279

1643

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

14.2

334

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

14.1

2444

21150

P06

ICPC

Sleep disturbance

1.4

14.1

607

4315

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

14.1

489

3328

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

14.1

619

4418

J01DC02

ATC

cefuroxime; systemic

1.6

14.1

372

2373

G54.0

ICD-10 Finland

Brachial plexus disorders

2.0

14.0

168

830

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

14.0

415

2726

R03BB01

ATC

ipratropium bromide; inhalant

2.0

14.0

179

908

J01AA04

ATC

lymecycline; systemic

1.4

14.0

868

6587

R06AX12

ATC

terfenadine; oral

1.7

14.0

303

1835

E000003

ATC

1.7

14.0

289

1724

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

14.0

291

1742

ZX120

NOMESCO Finland

Intravenous

1.5

14.0

512

3527

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

13.9

163

797

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

13.9

465

3135

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

13.9

161

787

J04.0

ICD-10 Finland

Acute laryngitis

1.8

13.9

244

1388

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

13.8

333

2076

L02

ICPC

Back symptom/complaint

1.4

13.8

582

4121

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

13.8

453

3043

N03AF01

ATC

carbamazepine; oral, rectal

1.7

13.7

275

1629

C05AA08

ATC

fluocortolone; rectal, topical

1.4

13.6

807

6076

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

13.6

2969

26279

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

13.5

290

1751

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

13.5

2567

22411

M54.3

ICD-10 Finland

Sciatica

1.6

13.5

337

2120

ZXA00

NOMESCO Finland

Right side

1.3

13.4

1455

11935

N06AA12

ATC

doxepin; systemic

1.7

13.4

282

1694

M22.4

ICD-10 Finland

Chondromalacia patellae

1.8

13.4

211

1155

L04

ICPC

Chest symptom/complaint

1.6

13.4

333

2092

S80.0

ICD-10 Finland

Contusion of knee

1.5

13.4

411

2723

E66.8

ICD-10 Finland

Other obesity

1.6

13.3

342

2170

J33.8

ICD-10 Finland

Other polyp of sinus

2.3

13.3

124

551

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

13.3

253

1477

UDC00

NOMESCO Finland

Ear microscopy

1.5

13.2

418

2787

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

3.2

13.2

214

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.1

13.2

139

654

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

13.1

414

2758

M01AH03

ATC

valdecoxib; oral

1.6

13.1

340

2160

L28.2

ICD-10 Finland

Other prurigo

5.4

13.1

R10.0

ICD-10 Finland

Acute abdomen

1.9

13.0

186

985

M48.0

ICD-10 Finland

Spinal stenosis

1.5

13.0

525

3690

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

13.0

750

5623

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

13.0

601

4336

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

12.9

420

2818

SPAT1097

SPAT

Recording of ECG

1.4

12.9

737

5516

G01AF05

ATC

econazole; vaginal

1.4

12.9

525

3695

WX722

NOMESCO Finland

PEEP

1.8

12.8

231

1324

49300

ICD-8 Finland

Asthma, bronchiale

2.2

12.8

131

606

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

12.8

1829

15480

P01

ICPC

Feeling anxious/nervous/tense

1.4

12.8

776

5864

A06AC51

ATC

ispaghula, combinations; systemic

1.7

12.7

284

1736

C10AC01

ATC

colestyramine; oral

2.0

12.7

161

817

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

12.7

592

4274

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

12.7

109

466

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

12.7

421

2839

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.7

734

5503

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.8

12.7

215

1211

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

12.6

393

2610

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

12.6

632

4627

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

12.5

146

716

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

2.2

12.5

129

600

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

12.4

2678

23610

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

12.4

695

5184

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

12.4

276

1686

L20

ICPC

Joint symptom/complaint NOS

1.8

12.4

212

1195

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

12.4

492

3443

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

12.3

100

415

A08

ICPC

Swelling

1.8

12.3

208

1171

H29

ICPC

Ear symptom/complaint other

1.4

12.3

544

3892

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

12.3

883

6849

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

12.2

832

6400

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

12.2

220

1263

R07.0

ICD-10 Finland

Pain in throat

1.5

12.1

401

2702

N03AE01

ATC

clonazepam; systemic

1.6

12.1

329

2115

K04

ICPC

Palpitations/awareness of heart

1.6

12.1

294

1840

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.7

12.1

226

1314

S87

ICPC

Dermatitis/atopic eczema

2.0

12.1

154

785

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

12.0

348

2273

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

12.0

283

1757

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

12.0

237

1399

S07

ICPC

Rash generalized

3.7

11.9

134

L28

ICPC

Limited function/disability (L)

1.4

11.9

743

5636

L30.0

ICD-10 Finland

Nummular dermatitis

1.9

11.9

177

951

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

11.9

2735

24231

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.1

11.9

134

648

R51

ICD-10 Finland

Headache

1.6

11.9

342

2235

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

11.8

152

777

R06.5

ICD-10 Finland

Mouth breathing

1.5

11.8

465

3250

-60

ICPC

Result test/procedure

1.6

11.8

329

2133

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

11.8

164

862

K59.0

ICD-10 Finland

Constipation

1.6

11.8

289

1814

L51.0

ICD-10 Finland

Nonbullous erythema multiforme

14.6

11.8

SPAT1104

SPAT

Monitoring of emergency patient

1.5

11.7

353

2329

L52

ICD-10 Finland

Erythema nodosum

5.8

11.7

R05DA01

ATC

ethylmorphine; oral

1.5

11.7

451

3139

D10

ICPC

Vomiting

1.5

11.7

415

2841

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

9.6

11.7

D02

ICPC

Abdominal pain epigastric

1.5

11.7

343

2248

J01AA07

ATC

tetracycline; systemic

1.3

11.7

1010

8038

N30

ICD-10 Finland

Cystitis

1.5

11.7

467

3274

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

11.6

216

1255

RD210

NOMESCO Finland

2.1

11.6

136

669

WX204

NOMESCO Finland

Axillary plexus blockaced

1.9

11.5

174

941

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

11.5

630

4676

D07XC01

ATC

betamethasone, combinations; topical

1.4

11.5

615

4551

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

11.5

605

4465

R06AE08

ATC

2.8

11.4

266

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.3

11.4

106

472

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

11.4

405

2776

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.0

11.4

144

733

TGC00

NOMESCO Finland

Bronchial lavation

2.1

11.3

125

598

R35

ICD-10 Finland

Polyuria

1.6

11.3

289

1829

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

11.3

357

2378

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.1

11.3

132

647

WQ000

NOMESCO Finland

Hyposensibilisation

3.3

11.3

162

D06BX01

ATC

metronidazole; topical

1.4

11.3

610

4522

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

11.2

498

3565

R06AX11

ATC

astemizole; oral

1.8

11.2

193

1094

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

11.2

134

666

SPAT1240

SPAT

Therapeutic discussion

1.3

11.2

738

5645

G01AF02

ATC

clotrimazole; vaginal

1.7

11.2

225

1337

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

11.2

608

4510

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

11.2

564

4133

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

11.2

117

550

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

11.2

334

2201

S20.2

ICD-10 Finland

Contusion of thorax

1.7

11.2

243

1476

Z54.0

ICD-10 Finland

Convalescence following surgery

2.2

11.2

106

475

N06AX12

ATC

bupropion; oral

1.5

11.2

395

2704

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

11.1

146

750

JAH01

NOMESCO Finland

Laparoscopy

1.6

11.1

276

1739

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

11.1

1120

9088

C10AA07

ATC

rosuvastatin; oral

1.3

11.1

1166

9509

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

11.1

296

1895

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.6

11.1

272

1708

XKC03

NOMESCO Finland

Water cystometry

1.9

11.1

168

912

S04

ICPC

Lump/swelling localized

1.4

11.0

536

3902

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

11.0

1427

11925

WX320

NOMESCO Finland

Spinalanesthesy

1.3

11.0

1257

10355

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.7

11.0

216

1276

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

11.0

185

1042

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.4

11.0

444

3122

A06AD11

ATC

lactulose; oral

1.4

10.9

646

4857

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

10.9

163

878

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.4

10.9

608

4529

SPAT1216

SPAT

Assessment of functional ability

1.3

10.9

729

5594

N06AB03

ATC

fluoxetine; oral

1.3

10.8

751

5790

M54.8

ICD-10 Finland

Other dorsalgia

1.7

10.8

228

1372

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

10.8

271

1709

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

10.8

376

2565

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

3.0

10.8

210

ZXA05

NOMESCO Finland

Left side

1.2

10.8

1341

11154

N03AG01

ATC

valproic acid; systemic, rectal

1.5

10.7

350

2353

R03DC01

ATC

zafirlukast; oral

2.3

10.7

394

DHB50

NOMESCO Finland

Turbinoplasty

1.9

10.7

151

800

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

10.7

464

3308

L20.8

ICD-10 Finland

Other atopic dermatitis

2.6

10.7

278

N06AB06

ATC

sertraline; oral

1.3

10.7

688

5247

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.1

10.7

111

522

SPAT1255

SPAT

Intravenous administration of medicine

1.5

10.6

328

2177

L29

ICD-10 Finland

Pruritus

2.4

10.6

350

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

10.6

356

2408

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.7

10.6

219

1312

L11

ICPC

Wrist symptom/complaint

1.4

10.6

492

3553

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

10.6

172

957

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.8

10.6

187

1071

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

10.6

502

3638

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

10.5

451

3205

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

10.5

164

900

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

10.5

352

2378

L60.0

ICD-10 Finland

Ingrowing nail

1.6

10.5

240

1477

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

10.5

823

6456

G04BD08

ATC

solifenacin; oral

1.6

10.5

299

1947

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

10.5

493

3569

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

10.5

241

1489

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

10.4

110

521

D82

ICPC

Teeth/gum disease

1.2

10.4

2360

20824

L51.8

ICD-10 Finland

Other erythema multiforme

110.1

10.4

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

10.4

180

1024

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

10.4

598

4479

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

10.4

475

3421

L86

ICPC

Back syndrome with radiating pain

1.5

10.4

308

2026

N05BA12

ATC

alprazolam; oral

1.4

10.3

580

4331

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

10.3

321

2136

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

10.3

273

N02AC04

ATC

dextropropoxyphene; oral

1.8

10.3

163

899

U04

ICPC

Incontinence urine

1.7

10.2

210

1256

R08

ICPC

Nose symptom/complaint other

1.7

10.2

191

1113

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.3

10.2

385

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

10.2

396

2762

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.7

10.2

191

1114

D05AX52

ATC

calcipotriol, combinations; topical

1.6

10.2

272

1745

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

10.2

1132

9290

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.2

206

1226

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

10.2

115

561

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

10.2

361

2473

-50

ICPC

Medication/prescr/renewal

1.7

10.2

223

1359

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

10.2

575

4295

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.0

10.2

130

665

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

10.1

112

540

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.4

10.1

330

N76.0

ICD-10 Finland

Acute vaginitis

1.4

10.1

408

2868

N03AF02

ATC

oxcarbazepine; oral

1.8

10.1

181

1039

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

10.1

204

1214

B02.9

ICD-10 Finland

Zoster without complication

1.6

10.1

276

1780

L29

ICPC

Musculoskeletal sympt/complt other

1.4

10.1

419

2963

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

10.1

746

5807

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

3.0

10.1

188

A02BA03

ATC

famotidine; systemic

1.8

10.1

175

995

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.6

10.1

266

1701

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

10.1

217

1317

D11AX14

ATC

[U] tacrolimus; topical

3.5

10.0

129

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

10.0

355

2430

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

10.0

129

660

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

10.0

286

1865

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.2

10.0

101

468

N89

ICPC

Migraine

1.6

10.0

225

1383

C08CA13

ATC

lercanidipine; oral

1.4

10.0

589

4432

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

10.0

147

792

D84.13

ICD-10 Finland

Hereditary angioedema type III

40.1

10.0

H01.0

ICD-10 Finland

Blepharitis

1.5

9.9

324

2183

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

9.8

238

1489

F34.1

ICD-10 Finland

Dysthymia

1.7

9.8

208

1257

D01AC02

ATC

miconazole; topical

1.5

9.8

384

2686

K80

ICPC

Cardiac arrhythmia NOS

1.5

9.8

365

2524

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

9.8

1315

11023

G43.3

ICD-10 Finland

Complicated migraine

2.0

9.7

112

551

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

9.7

125

643

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

9.7

131

686

D07AC14

ATC

methylprednisolone aceponate; topical

1.6

9.7

260

1671

R12

ICD-10 Finland

Heartburn

1.4

9.7

393

2769

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

9.7

789

6227

L30.8

ICD-10 Finland

Other specified dermatitis

2.0

9.6

124

638

-1

NOMESCO Finland

1.2

9.6

2326

20614

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

9.6

354

2447

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

9.6

138

737

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

9.6

1881

16362

1220

FHL

Arthroscopy

1.7

9.6

199

1196

E0001A1

ATC

1.9

9.6

144

781

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

9.6

242

1535

SPAT1262

SPAT

Handing over of treatment supplies

1.3

9.6

896

7200

SPAT1229

SPAT

Assessment of need for aid

1.5

9.5

357

2474

T82

ICPC

Obesity

1.6

9.5

223

1384

P03

ICPC

Feeling depressed

1.3

9.5

627

4800

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

9.5

319

2159

G03DB01

ATC

dydrogesterone; oral

1.3

9.5

878

7044

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.9

9.5

131

690

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

9.5

292

1941

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.8

9.5

155

868

U71

ICPC

Cystitis/urinary infection other

1.5

9.5

352

2434

Z00.8

ICD-10 Finland

Other general examinations

1.4

9.4

411

2932

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

9.4

281

1855

N39.3

ICD-10 Finland

Stress incontinence

1.4

9.4

397

2818

D73

ICPC

Gastroenteritis presumed infection

1.7

9.4

185

1094

WX892

NOMESCO Finland

Monitored bed care

1.5

9.4

367

2564

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

2.7

9.4

233

7083A

ICD-9 Finland

Urticaria, Dermatographic urticaria

+∞

9.4

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

9.4

2045

17954

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

9.4

233

1471

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.7

9.4

221

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

9.3

320

2175

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

9.3

228

1433

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

9.3

284

1882

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

9.3

359

2505

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

9.3

366

2563

XKD00

NOMESCO Finland

Uroflowmetry

1.3

9.3

567

4287

B81

ICPC

Anaemia vit B12/folate deficiency

1.7

9.3

168

971

L18

ICPC

Muscle pain

1.6

9.2

207

1271

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

9.2

1962

17186

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

9.2

278

1841

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

9.2

267

1750

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

9.2

1176

9804

C09CA01

ATC

losartan; oral

1.2

9.2

1149

9555

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

9.2

503

3739

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

9.2

451

3294

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

9.1

130

692

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

9.1

408

2929

R4120

NOMESCO Finland

Occupational therapy

1.5

9.1

340

2358

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

9.1

202

1240

N02CC06

ATC

eletriptan; oral

1.6

9.0

225

1422

L28.1

ICD-10 Finland

Prurigo nodularis

3.4

9.0

125

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

9.0

610

4689

R05DB05

ATC

pentoxyverine; oral, rectal

1.7

9.0

193

1169

OAA65

SPAT

1.3

9.0

625

4821

L50.69

ICD-10 Finland

Other (non-immunological) contact urticaria

36.7

9.0

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

9.0

477

3528

L26

ICD-10 Finland

Exfoliative dermatitis

9.0

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

9.0

203

1252

S76

ICPC

Skin infection other

1.6

8.9

246

1593

4452

FHL

Tonsil surgery

1.6

8.9

206

1276

F29

ICPC

Eye symptom/complaint other

1.4

8.9

462

3402

N07CA01

ATC

betahistine; oral

1.5

8.9

342

2383

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.3

8.9

361

M10.9

ICD-10 Finland

Gout, unspecified

1.6

8.9

228

1450

U02

ICPC

Urinary frequency/urgency

1.3

8.9

749

5933

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

3.1

8.9

154

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

8.9

157

903

R29

ICPC

Respiratory symptom/complaint other

1.4

8.9

347

2428

L73.8

ICD-10 Finland

Other specified follicular disorders

2.8

8.8

204

G04BD12

ATC

mirabegron; oral

1.4

8.8

434

3169

315

Kela drug reimbursment

Clopidogrel

3.0

8.8

166

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.9

8.8

176

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

8.8

252

1649

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.6

8.8

102

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

8.8

622

4811

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

8.7

250

1637

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

8.7

761

6059

A29

ICPC

General symptom/complaint other

1.3

8.7

565

4312

G43

ICD-10 Finland

Migraine

1.5

8.7

305

2087

M04AA01

ATC

allopurinol; systemic

1.4

8.7

475

3530

P25

ICPC

Phase of life problem adult

1.5

8.7

260

1717

N02CC04

ATC

rizatriptan; oral

1.4

8.7

373

2657

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

8.7

159

924

SFA00

NOMESCO Finland

Small filling

1.3

8.7

739

5864

D84.1

ICD-10 Finland

Defects in the complement system

14.0

8.7

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

8.7

281

1892

D19

ICPC

Teeth/gum symptom/complaint

1.2

8.7

1715

14913

H60

ICD-10 Finland

Otitis externa

1.5

8.7

261

1726

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

8.6

364

2586

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.6

8.6

209

1311

E66.00

ICD-10 Finland

Metabolic syndrome

1.5

8.6

264

1756

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

8.6

432

3166

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

8.6

124

666

K07

ICPC

Swollen ankles/oedema

1.7

8.6

179

1080

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.1

8.6

447

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

8.6

701

5536

KMAK

NOMESCO Finland

1.1

8.5

3621

33428

XCK00

NOMESCO Finland

Perimetry

1.5

8.5

310

2140

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

8.5

159

929

WQ066

NOMESCO Finland

9.0

8.5

N04BC05

ATC

pramipexole; oral

1.4

8.5

337

2365

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.9

8.5

168

N06AA10

ATC

nortriptyline; systemic

1.9

8.5

121

647

R52.0

ICD-10 Finland

Acute pain

1.7

8.5

171

1021

D69.0

ICD-10 Finland

Allergic purpura

3.1

8.5

148

S08

ICPC

Skin colour change

1.6

8.5

239

1557

K04.08

ICD-10 Finland

Other specified pulpit

1.4

8.5

396

2866

F32.1

ICD-10 Finland

Moderate depressive episode

1.4

8.5

346

2442

M02AA10

ATC

ketoprofen; topical

1.3

8.4

828

6693

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

2.3

8.4

312

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

8.4

796

6404

UJD02

NOMESCO Finland

Gastroscopy

1.6

8.4

229

1484

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

8.4

120

643

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

8.4

195

1213

JEA00

NOMESCO Finland

Appendectomy

1.4

8.3

360

2567

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

8.3

190

1175

G44.0

ICD-10 Finland

Cluster headache syndrome

2.3

8.3

314

J35.0

ICD-10 Finland

Chronic tonsillitis

1.4

8.3

360

2568

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.7

8.3

150

866

Y1208

ICD-8 Finland

Other skin tests

+∞

8.3

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.8

8.3

135

753

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

8.3

637

4983

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

8.3

2121

18837

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

8.3

323

2259

NBG10

NOMESCO Finland

Acromioplastia

1.9

8.3

113

594

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.0

8.3

151

J01CF05

ATC

flucloxacillin; systemic

1.6

8.3

184

1131

E03

ICD-10 Finland

Other hypothyroidism

1.5

8.3

315

2193

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

8.2

710

5641

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

8.2

811

6555

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

8.2

179

1094

T86

ICPC

Hypothyroidism/myxoedema

1.6

8.2

207

1315

R4190

NOMESCO Finland

Nutritional therapy

1.6

8.2

205

1298

T83

ICPC

Overweight

1.9

8.2

113

598

N02CC05

ATC

almotriptan; oral

1.5

8.2

265

1782

D72.1

ICD-10 Finland

Eosinophilia

4.0

8.2

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

8.2

351

2501

G01AA10

ATC

clindamycin; vaginal

1.2

8.2

965

7964

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

8.2

476

3577

K11.2

ICD-10 Finland

Sialoadenitis

1.7

8.2

168

1011

D07AB01

ATC

clobetasone; topical

1.6

8.2

180

1105

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.2

8.2

335

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

8.2

122

663

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

8.1

120

649

ACC51

NOMESCO Finland

Release of median nerve

1.4

8.1

382

2767

K04.0

ICD-10 Finland

Pulpitis

1.3

8.1

592

4598

S01GX09

ATC

olopatadine; ophthalmic

1.7

8.1

162

964

A02BX02

ATC

sucralfate; oral

1.6

8.1

189

1174

M23.8

ICD-10 Finland

Other internal derangements of knee

1.6

8.1

202

1277

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

8.1

430

3180

L56.4

ICD-10 Finland

Polymorphous light eruption

3.9

8.1

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

8.1

695

5522

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

8.1

664

5245

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

8.1

381

2761

S99

ICPC

Skin disease other

2.0

8.1

475

-34

ICPC

Blood test

1.7

8.1

160

951

P76

ICPC

Depressive disorder

1.4

8.1

385

2797

K85

ICPC

Elevated blood pressure

1.3

8.0

667

5276

R25.2

ICD-10 Finland

Cramp and spasm

1.8

8.0

121

660

H10

ICD-10 Finland

Conjunctivitis

1.4

8.0

368

2655

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.7

8.0

156

922

R83

ICPC

Respiratory infection other

1.2

8.0

1713

14986

338

Kela drug reimbursment

C1-esterase inhibitor, icatibant and conestat alfa

22.0

8.0

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

8.0

204

1299

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

8.0

521

3982

C10AX09

ATC

ezetimibe; oral

1.4

8.0

452

3382

A10BA02

ATC

metformin; oral

1.2

8.0

1272

10837

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

8.0

324

2288

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.1

7.9

414

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.1

7.9

128

N03AX11

ATC

topiramate; oral

1.7

7.9

160

957

L28.0

ICD-10 Finland

Lichen simplex chronicus

2.5

7.9

221

C09AA02

ATC

enalapril; systemic

1.3

7.9

852

6960

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

7.9

124

688

J01CA08

ATC

pivmecillinam; oral

1.2

7.9

2773

25211

S01AD03

ATC

aciclovir; ophthalmic

1.6

7.9

182

1131

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

7.9

492

3736

S22.3

ICD-10 Finland

Fracture of rib

1.5

7.9

277

1902

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

7.9

2522

22779

H93.1

ICD-10 Finland

Tinnitus

1.4

7.8

321

2268

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.7

7.8

140

807

A11

ICPC

Chest pain NOS

1.4

7.8

346

2480

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

7.8

854

6985

M01AX05

ATC

glucosamine; oral

1.2

7.8

912

7517

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

7.8

119

653

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.8

429

3196

N06AB05

ATC

paroxetine; oral

1.4

7.8

355

2562

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

7.8

117

639

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.8

1232

10487

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

7.8

157

940

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.2

7.7

353

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

7.7

201

1286

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

7.7

185

1160

XQ809

NOMESCO Finland

15.0

7.7

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.6

7.7

190

1203

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

7.7

178

1106

F32

ICD-10 Finland

Depressive episode

1.4

7.7

316

2237

H65.0

ICD-10 Finland

Acute serous otitis media

1.9

7.7

100

520

N06AX26

ATC

vortioxetine; oral

1.4

7.6

324

2305

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.0

7.6

456

LEG12

NOMESCO Finland

Transobturatoric tape

2.1

7.6

409

M77.4

ICD-10 Finland

Metatarsalgia

1.4

7.6

308

2172

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.4

7.6

336

2411

S01GX02

ATC

levocabastine; ophthalmic

1.4

7.6

374

2732

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

7.6

319

2266

C03AA03

ATC

hydrochlorothiazide; oral

1.4

7.6

410

3046

XG405

NOMESCO Finland

Education on PEF monitoring

2.1

7.6

376

B06AC02

ATC

icatibant; parenteral

25.0

7.6

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.6

7.6

172

1065

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

2.4

7.5

244

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

7.5

522

4030

G04CA02

ATC

tamsulosin; oral

1.3

7.5

685

5484

S01GX08

ATC

ketotifen; ophthalmic

1.5

7.5

219

1443

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.5

7.5

216

A01AB04

ATC

amphotericin B; local oral

1.5

7.5

232

1548

SPAT1059

SPAT

Spirometry at the office

1.5

7.4

247

1676

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

7.4

859

7075

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

7.4

229

1529

C08CA02

ATC

felodipine; oral

1.4

7.4

373

2738

WW200

NOMESCO Finland

Immunization

1.7

7.4

152

914

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.7

7.4

131

756

A28

ICPC

Limited function/disability NOS

1.3

7.4

579

4547

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

7.4

255

1744

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.5

7.4

275

1911

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

5.9

7.4

C07AG02

ATC

carvedilol; oral

1.5

7.3

229

1532

D06BB03

ATC

aciclovir; topical

1.5

7.3

270

1869

L04AB04

ATC

adalimumab; parenteral

1.8

7.3

109

593

N02AJ13

ATC

tramadol and paracetamol; systemic

1.9

7.3

103

550

C10AA01

ATC

simvastatin; oral

1.2

7.3

1905

16922

7081A

ICD-9 Finland

Urticaria, Idiopathic urticaria

+∞

7.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

7.3

387

2866

T78.9

ICD-10 Finland

Adverse effect, unspecified

10.8

7.3

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.9

7.3

107

581

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.4

7.3

R03AA01

ATC

epinephrine; inhalant

9.3

7.3

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

7.3

133

774

C08DA01

ATC

verapamil; systemic

1.6

7.2

185

1181

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

7.2

219

1454

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.6

7.2

180

1140

L20

ICD-10 Finland

Atopic dermatitis

1.6

7.2

162

998

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

7.2

303

2154

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

7.2

746

6066

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.0

7.2

447

9950A

ICD-9 Finland

Certain adverse effects not elsewhere classified, Other anaphylactic shock

15.7

7.2

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.4

7.2

382

2831

R49.01

ICD-10 Finland

Functional dysphonia

1.7

7.2

155

945

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

7.2

503

L71.9

ICD-10 Finland

Rosacea, unspecified

1.8

7.2

118

666

A77

ICPC

Viral disease other/NOS

1.5

7.2

211

1395

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

2.3

7.1

259

S02CA02

ATC

flumetasone and antiinfectives; otic

1.4

7.1

279

1955

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

7.1

161

996

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

7.1

132

773

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

2.1

7.1

344

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.6

7.1

169

1058

Y34

ICD-10 Finland

Unspecified event, undetermined intent

2.9

7.1

133

NBE45

NOMESCO Finland

Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic

2.2

7.1

300

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.4

7.1

241

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.3

7.1

272

A07EC02

ATC

mesalazine; oral, rectal

1.4

7.0

289

2045

S19

ICPC

Skin injury other

1.6

7.0

176

1117

RS221

NOMESCO Finland

2.0

7.0

423

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

2.0

7.0

423

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.4

7.0

296

2108

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.2

7.0

295

M70.2

ICD-10 Finland

Olecranon bursitis

1.7

7.0

122

703

SPAT1325

SPAT

Vaccination

1.2

7.0

1968

17575

R5599

NOMESCO Finland

Other rehabilitation service

1.7

7.0

141

846

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.6

7.0

161

1001

C10AA05

ATC

atorvastatin; oral

1.2

7.0

1733

15326

D01AE16

ATC

amorolfine; topical

1.3

7.0

559

4402

J38.4

ICD-10 Finland

Oedema of larynx

3.1

7.0

118

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

6.9

383

2855

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

6.9

288

2045

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

4.4

6.9

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

6.9

332

2420

T90

ICPC

Diabetes non-insulin dependent

1.2

6.9

1013

8550

E66

ICD-10 Finland

Obesity

1.5

6.9

236

1611

Z30.2

ICD-10 Finland

Sterilization

1.3

6.9

616

4920

D03

ICPC

Heartburn

1.6

6.9

167

1054

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.5

6.9

197

1295

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.9

6.9

100

542

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

1.8

6.9

119

683

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

6.9

152

936

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.0

6.9

394

M05BA04

ATC

alendronic acid; oral

1.4

6.9

343

2515

SPAT1281

SPAT

Other administrative function

1.3

6.8

439

3353

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

6.8

166

1046

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.9

6.8

477

M01AX01

ATC

nabumetone; oral

1.5

6.8

211

1411

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.7

6.8

141

853

D01BA02

ATC

terbinafine; oral; topical

1.2

6.8

1265

10920

R49.0

ICD-10 Finland

Dysphonia

2.0

6.8

424

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.8

6.8

116

662

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.2

6.8

306

JN4BD

NOMESCO Finland

Extensive body CT

1.3

6.8

484

3752

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

6.8

230

1570

NG2AA

NOMESCO Finland

Patella X-ray examination

1.7

6.8

127

748

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.5

6.8

207

L50.60

ICD-10 Finland

Allergic contact urticaria

9.3

6.8

F01

ICPC

Eye pain

1.6

6.8

149

917

XQ845

NOMESCO Finland

Dermatoscopy

2.3

6.8

265

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.8

6.8

101

554

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

6.8

121

700

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

3.6

6.7

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

6.7

410

3106

M15

ICD-10 Finland

Polyarthrosis

1.5

6.7

204

1358

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.1

6.7

321

H02

ICPC

Hearing complaint

1.3

6.7

493

3840

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.0

6.7

405

R04.0

ICD-10 Finland

Epistaxis

1.4

6.7

287

2052

R20.0

ICD-10 Finland

Anaesthesia of skin

2.7

6.7

151

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

6.7

971

8191

RS222

NOMESCO Finland

2.2

6.6

290

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

6.6

122

713

M01AB51

ATC

indometacin, combinations; oral, rectal

1.8

6.6

109

614

L90

ICPC

Osteoarthrosis of knee

1.4

6.6

260

1828

F43.0

ICD-10 Finland

Acute stress reaction

1.4

6.6

278

1976

G50.1

ICD-10 Finland

Atypical facial pain

1.9

6.6

478

S97

ICPC

Chronic ulcer skin

1.5

6.6

206

1381

H81.0

ICD-10 Finland

Ménière disease

1.8

6.6

111

632

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.6

6.6

149

921

XW000

NOMESCO Finland

Bone marrow biopsy

1.6

6.6

170

1087

XG466

NOMESCO Finland

Sleep oxymetry

1.6

6.6

144

883

L05

ICPC

Flank/axilla symptom/complaint

1.4

6.6

265

1870

C03DA01

ATC

spironolactone; oral

1.3

6.6

445

3423

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.8

6.6

107

603

S10

ICPC

Boil/carbuncle

1.4

6.6

269

1904

H15.1

ICD-10 Finland

Episcleritis

2.0

6.6

401

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

2.4

6.6

205

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.5

349

2588

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.2

6.5

265

K04.00

ICD-10 Finland

Hyperemia of pulp

1.4

6.5

250

1749

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

6.5

130

780

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.7

6.5

119

694

S16

ICPC

Bruise/contusion

1.6

6.5

143

878

C10AA03

ATC

pravastatin; oral

1.4

6.5

268

1901

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

6.5

1423

12454

L71.8

ICD-10 Finland

Other rosacea

2.0

6.5

369

M09AX01

ATC

hyaluronic acid; parenteral

1.5

6.5

189

1249

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.7

6.5

117

682

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.2

6.5

D01AE15

ATC

terbinafine; topical

1.4

6.5

317

2321

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.9

6.4

510

L04AA17

ATC

[U] adalimumab; parenteral

3.7

6.4

Y1202

ICD-8 Finland

Skin tests, Allergy tests

3.8

6.4

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

6.4

636

5146

R07

ICPC

Sneezing/nasal congestion

1.3

6.4

400

3043

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.6

6.4

139

852

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

6.4

1688

14985

F32.8

ICD-10 Finland

Other depressive episodes

1.9

6.4

469

L03AX13

ATC

glatiramer acetate; parenteral

2.7

6.4

143

D01AC03

ATC

econazole; topical

1.4

6.4

279

2000

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

6.4

130

782

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

1.7

6.4

118

692

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

3.0

6.4

109

50708

ICD-8 Finland

Hay fever, Alia definita

3.0

6.4

109

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

6.4

241

1682

U07

ICPC

Urine symptom/complaint other

1.4

6.4

269

1919

GD1AA

SPAT

1.3

6.3

388

2946

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

6.3

359

2690

JN4AD

NOMESCO Finland

Body CT examination

1.4

6.3

315

2313

M54.1

ICD-10 Finland

Radiculopathy

1.5

6.3

193

1286

SPAT1360

SPAT

Extensive global examination

1.3

6.3

369

2778

L56.3

ICD-10 Finland

Solar urticaria

5.2

6.3

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

6.3

184

1218

Y96.9

ICD-10 Finland

Unspecified type of accident

1.9

6.3

465

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.6

6.3

169

WVA20

NOMESCO Finland

Medicine administration

1.8

6.3

100

559

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.7

6.2

111

642

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

6.2

236

1646

R15

ICD-10 Finland

Faecal incontinence

1.7

6.2

122

730

B07.9

ICD-10 Finland

Verruca simplex

1.5

6.2

189

1262

SPAT1238

SPAT

Brief therapy

1.7

6.2

120

716

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.7

6.2

118

700

J03

ICD-10 Finland

Acute tonsillitis

1.6

6.2

153

975

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.5

6.2

176

1156

A02BA01

ATC

cimetidine; systemic

5.0

6.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.5

6.2

196

1323

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.3

6.2

355

2669

D11AH02

ATC

pimecrolimus; topical

3.1

6.2

101

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.3

6.1

441

3423

ULC02

NOMESCO Finland

Hysteroscopy

1.4

6.1

285

2067

R03CC02

ATC

salbutamol; systemic

1.3

6.1

409

3144

LCA06

NOMESCO Finland

Biopsy of endometrium

1.2

6.1

706

5814

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.2

6.1

719

5933

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

2.5

6.1

184

XCK10

NOMESCO Finland

Photography of fundus of eye

1.3

6.1

447

3482

A01AB10

ATC

natamycin; local oral

1.6

6.1

152

967

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

6.1

152

968

L84

ICPC

Back syndrome without radiat pain

1.5

6.1

217

1496

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

6.1

147

928

D10AF01

ATC

clindamycin; topical

1.4

6.1

294

2149

R09.1

ICD-10 Finland

Pleurisy

1.9

6.1

442

1410

FHL

Laparoscopy

1.6

6.1

150

955

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.3

6.0

512

4066

CS494

NOMESCO Finland

Other visual field testing

1.8

6.0

102

582

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.1

6.0

302

F61.0

ICD-10 Finland

Mixed personality disorders

1.8

6.0

533

Z50.1

ICD-10 Finland

Other physical therapy

1.4

6.0

263

1889

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.7

6.0

104

600

N63

ICD-10 Finland

Unspecified lump in breast

1.3

6.0

358

2705

S83.2

ICD-10 Finland

Tear of meniscus, current

1.3

6.0

346

2600

A97

ICPC

No disease

1.2

6.0

843

7085

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

335

215

16.15

307.65

1.3

1.2

0.3

g/l

0.43

261

168

(3019420) Tryptase [Mass/volume] in Serum or Plasma

472

362

13.71

307.65

1.3

1.5

5.5

7.8

ug/l

2.62

418

320

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

325

197

17.08

307.65

1.3

1.2

109.7

111.9

0.48

301

175

(3005322) IgE [Units/volume] in Serum or Plasma

1570

5115

3.51

307.65

1.5

1.3

239.9

203.4

u/ml

0.96

1489

4726

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

829

2208

4.03

274.03

1.9

1.8

0.2

g/l

1.13

773

2094

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

834

2274

3.94

266.60

1.9

1.8

1.2

g/l

0.33

780

2159

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

178

23.87

248.90

1.1

1.2

0.2

0.0

u/ml

0.49

(3013115) Eosinophils [#/volume] in Blood

5337

38151

1.98

208.04

7.2

6.2

0.2

e9/l

5.35

4844

33664

(3006315) Basophils [#/volume] in Blood

5182

36841

1.96

203.20

7.0

6.0

0.0

e9/l

0.79

4643

31938

(3001604) Monocytes [#/volume] in Blood

5164

36698

1.96

202.41

6.9

6.0

0.6

e9/l

1.41

4629

31843

(3019198) Lymphocytes [#/volume] in Blood

5277

37949

1.95

197.62

7.0

6.0

2.0

e9/l

0.21

4813

33583

(42870588) Differential panel, method unspecified - Blood

3791

24439

1.95

196.85

6.8

6.1

—

(3006504) Eosinophils/100 leukocytes in Blood

4899

34466

1.93

194.87

7.2

6.1

3.0

2.8

3.13

4606

32157

(3019069) Monocytes/100 leukocytes in Blood

4917

34663

1.92

194.07

7.4

6.4

8.1

8.4

6.94

4648

32544

(3022096) Basophils/100 leukocytes in Blood

4762

33347

1.91

190.40

7.3

6.2

0.6

0.7

5.62

4484

31135

(3002030) Lymphocytes/100 leukocytes in Blood

5010

35874

1.90

184.80

7.3

6.1

28.9

29.1

0.83

4722

33523

(3018010) Neutrophils/100 leukocytes in Blood

4943

35360

1.88

181.58

6.9

5.9

56.7

56.4

1.11

4660

33176

(3037522) Nuclear Ab [Titer] in Serum

2006

10591

2.15

178.50

1.5

1.4

560.0

555.8

titre

0.03

433

2189

(3013707) Erythrocyte sedimentation rate by Westergren method

6725

54169

1.96

160.46

5.0

3.9

11.1

11.0

mm/h

0.45

6340

50489

(3013650) Neutrophils [#/volume] in Blood by Automated count

5563

42395

1.82

155.54

9.5

9.0

4.1

4.0

e9/l

2.56

5019

37029

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6587

54281

1.80

126.18

8.4

7.1

77.2

u/l

0.01

6232

51172

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4663

35586

1.65

112.39

6.1

5.9

10.5

11.0

umol/l

1.61

4404

33614

(3037467) Urinalysis macro (dipstick) panel - Urine

6158

50534

1.70

111.01

5.0

4.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

16.04

104.38

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

138

180

7.77

99.17

1.1

3.4

0.6

u/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4350

33374

1.59

96.80

7.5

6.5

1.2

mmol/l

0.49

3674

28241

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3995

30159

1.58

94.46

6.8

5.9

1.2

mmol/l

0.23

3608

27443

(3031040) Bacteria [#/volume] in Urine by Automated count

5845

48297

1.60

92.79

5.1

4.2

1150.0

1559.1

e6/l

0.29

577

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3044

21720

1.61

90.27

2.8

2.5

54.6

57.6

u/l

3.46

2785

20075

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

575

2344

2.55

90.04

2.0

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2797

19566

1.62

89.93

2.3

2.1

141.4

203.9

u/l

6.02

2627

18426

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2047

13424

1.68

83.88

1.4

1.3

28.8

30.3

iu/ml

0.16

599

4187

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1968

12780

1.69

83.66

1.3

11.2

u/ml

0.00

729

5203

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6851

59541

1.64

81.51

4.9

4.1

14.7

14.6

pmol/l

2.93

6320

54843

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3231

23796

1.56

81.45

3.7

3.2

35.2

66.4

ng/l

0.76

1904

14147

(3007164) IgA [Mass/volume] in Serum or Plasma

2356

16149

1.62

80.57

1.5

1.4

2.2

2.3

g/l

0.44

1436

9938

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8191

75055

2.04

79.15

16.7

12.2

19.1

21.7

mg/l

12.61

6902

58177

(3004616) Nuclear Ab [Presence] in Serum

290

875

3.39

78.30

1.4

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2631

18699

1.58

76.47

1.4

1.3

1.5

1.7

u/ml

0.27

663

5114

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7692

69296

1.77

75.54

5.8

4.8

1.8

2.0

mu/l

2.40

7177

64502

(40768443) Skin Pathology biopsy report

640

2990

2.23

73.34

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1096

6229

1.87

72.86

1.3

1.2

117.6

150.6

iu/ml

2.16

397

2400

(3013826) Glucose [Moles/volume] in Serum or Plasma

4957

40663

1.49

71.43

5.1

4.4

6.6

6.5

mmol/l

0.31

4640

37451

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

9.22

70.37

1.0

0.1

u/ml

0.15

(3009445) Proteinase 3 Ab [Units/volume] in Serum

596

2752

2.25

70.20

1.5

1.6

28.1

12.6

u/ml

0.69

(3015171) Extractable nuclear Ab [Units/volume] in Serum

646

3083

2.18

70.14

1.3

1.7

1.0

u/ml

0.43

268

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

402

1563

2.65

69.11

1.3

2.5

3.6

u/ml

0.32

116

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

395

1523

2.67

69.05

1.3

1.2

0.7

16.4

u/ml

—

(3042951) Complement C1q Ab [Units/volume] in Serum

19.74

68.58

1.4

1.0

10.8

30.4

u/ml

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2296

16143

1.57

68.52

2.1

1.8

1.1

mg/l

0.08

1681

12109

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

617

2933

2.19

67.60

1.6

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

506

2217

2.36

67.37

1.6

442.6

344.9

titre

0.25

(3019225) pH of Specimen

1101

6412

1.82

67.32

4.3

4.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

951

5304

1.89

66.73

2.5

2.3

18.3

24.0

au/ml

0.89

355

(3032080) INR in Blood by Coagulation assay

3290

25148

1.49

65.68

7.6

7.5

1.2

inr

0.45

996

7619

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

30.86

65.57

1.0

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

990

5641

1.85

64.84

2.9

2.7

10.4

g/l

0.04

901

5194

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2460

17741

1.53

64.80

1.8

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

885

4872

1.91

64.54

1.3

33.5

47.0

au/ml

0.77

201

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

457

1959

2.40

63.87

1.4

1.3

8.4

8.0

u/ml

0.04

317

(3012494) Peanut IgE Ab [Units/volume] in Serum

138

280

4.99

63.82

1.1

1.2

1.5

15.3

u/ml

0.66

165

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

452

1932

2.41

63.58

1.4

1.3

5.7

5.6

u/ml

0.02

192

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3457

26816

1.47

63.42

2.1

1.9

98.7

97.4

pmol/l

0.87

1896

14008

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3864

30645

1.46

63.06

2.7

2.3

75.5

76.0

nmol/l

0.50

3517

28060

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

482

2146

2.32

61.77

1.4

1.3

31.8

41.7

u/ml

0.36

140

(3048689) Calprotectin [Mass/mass] in Stool

1578

10381

1.63

61.42

2.5

2.4

105.9

121.5

ug/g

1.28

1220

8129

(3019550) Sodium [Moles/volume] in Serum or Plasma

8059

74466

1.80

61.15

17.2

13.4

139.6

mmol/l

2.03

7881

72520

(3024561) Albumin [Mass/volume] in Serum or Plasma

3670

28950

1.45

60.93

5.1

4.8

36.0

36.1

g/l

0.32

3419

26942

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

196

544

3.66

60.14

1.3

1.2

46.7

48.1

u/ml

0.02

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

195

541

3.66

59.87

1.2

88.8

58.8

u/ml

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

322

1203

2.74

59.83

1.2

242.9

225.5

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8069

74697

1.79

59.30

17.4

13.5

3.9

mmol/l

1.51

7876

72569

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

111

198

5.66

59.24

1.1

1.2

1.1

12.2

u/ml

2.16

143

(40768797) Stomach Pathology biopsy report

1474

9619

1.64

59.02

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

159

6.28

58.82

1.3

1.4

0.7

6.8

u/ml

1.58

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

8.04

58.74

1.1

0.0

0.4

u/ml

0.96

(3013512) EKG study

2482

18257

1.50

58.30

3.8

3.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

100

7.96

58.25

1.1

1.0

0.2

0.6

u/ml

0.40

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

8.38

56.90

1.1

1.0

0.2

0.7

u/ml

0.66

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

185

520

3.61

55.72

1.2

2.2

10.4

u/ml

0.93

(3019309) Folate [Moles/volume] in Red Blood Cells

1650

11251

1.57

54.52

1.8

1.7

1150.4

1169.2

nmol/l

0.36

1266

8620

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1134

7070

1.69

53.79

2.3

2.2

350.1

374.1

nmol/l

4.00

1042

6512

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1267

8132

1.65

53.74

4.3

4.1

31.8

32.5

1.30

944

5707

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

400

1749

2.35

53.37

1.4

1.5

31.1

13.9

iu/ml

0.68

(40758558) Short blood count panel - Blood

2472

18459

1.47

52.80

7.3

6.9

—

(3023368) Bacteria identified in Blood by Culture

2264

16643

1.48

52.27

4.4

4.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

405

1811

2.29

51.29

1.1

4.7

5.8

u/ml

0.76

250

973

(3026493) Urate [Moles/volume] in Serum or Plasma

2329

17322

1.47

50.32

2.8

2.5

2388.7

3886.6

umol/l

1.64

2019

15235

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2161

15901

1.47

49.13

3.3

2.9

1115.7

1174.1

ng/l

0.24

1754

13398

(3013139) Helicobacter pylori Ag [Presence] in Stool

855

5055

1.76

48.86

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

760

4351

1.82

48.40

1.9

1.8

1.3

g/l

0.09

692

4027

(3018095) Leukocytes [#/volume] in Urine

3133

24741

1.41

48.30

4.1

3.5

74.6

90.4

e6/l

0.51

2265

16862

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5830

51077

1.40

48.15

3.6

3.0

44.2

42.0

u/l

1.38

5499

48153

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

800

4674

1.78

47.57

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1264

8337

1.60

47.53

1.9

1.7

—

(3021589) Normoblasts [#/volume] in Blood

3978

32823

1.38

46.70

10.7

9.0

0.0

e9/l

0.33

3316

26738

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

10.25

46.60

1.0

0.1

0.3

u/ml

0.60

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2319

17481

1.44

45.87

2.5

2.2

2.9

2.8

mg/l

0.67

2006

15040

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7439

68369

1.51

45.81

14.0

11.1

86.8

86.3

ml/min/173m2

1.00

6343

55946

(4010399)

812

4822

1.75

45.56

1.4

—

(3026782) Osmolality of Urine

1820

13146

1.48

44.83

3.0

2.7

538.8

539.0

mosm/kgh2o

0.01

1614

11159

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4218

35303

1.37

44.49

3.4

2.9

112.9

100.2

ug/l

1.41

3926

33124

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8352

79060

1.81

44.04

12.3

9.5

26.3

25.9

u/l

0.83

8130

76519

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1520

10625

1.52

43.81

3.8

3.7

0.8

mmol/l

0.45

1397

9951

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

703

4049

1.80

43.75

4.7

4.3

1.3

1.6

mmol/l

1.99

543

2955

(3008401) Mugwort IgE Ab [Units/volume] in Serum

374

1736

2.20

43.24

1.1

1.5

1.2

u/ml

0.36

205

772

(3002582) Erythrocytes [#/volume] in Urine

2633

20489

1.40

42.99

3.6

3.1

56.0

77.4

e6/l

0.68

2099

15462

(3009343) pH of Capillary blood

717

4176

1.78

42.94

4.7

4.3

7.4

0.40

500

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

723

4224

1.77

42.84

4.7

4.3

5.1

kpa

0.95

679

3946

(40760892) CBC W Ordered Manual Differential panel - Blood

2260

17135

1.43

42.76

5.0

4.2

—

(3030467) Casts [#/volume] in Urine by Automated count

2447

18821

1.41

42.68

3.4

3.0

0.3

0.4

e6/l

1.04

1910

13967

(36660697) Celiac disease serology panel - Serum

1037

6713

1.62

41.78

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

170

546

3.15

41.53

1.3

0.8

1.3

u/ml

0.31

223

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

113

6.24

41.43

1.1

2.6

3.7

u/ml

0.18

(3035350) Ketones [Presence] in Urine by Test strip

4267

36025

1.35

41.36

3.9

3.4

0.0

estimate

1.08

865

6792

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1071

7005

1.60

41.31

4.7

4.2

246.6

242.3

u/l

0.28

1014

6623

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3021

24179

1.38

41.23

3.2

31.0

33.6

u/l

1.30

2856

23017

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

145

426

3.44

40.91

1.7

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1446

10142

1.51

40.71

2.0

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

1909

14147

1.44

40.60

2.9

2.5

6.5

6.6

e6/l

0.06

1685

12346

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

408

2012

2.08

40.36

1.2

1.1

1.7

1.9

u/ml

0.17

219

833

(36304419) Bacteria [Presence] in Urine

2401

18578

1.40

39.92

3.4

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

4271

36180

1.34

39.92

5.3

4.7

0.0

estimate

1.34

900

6986

(3021440) Promyelocytes/100 leukocytes in Blood

886

5583

1.65

39.67

4.5

4.2

0.1

0.2

1.99

246

1390

(3009261) Glucose [Presence] in Urine by Test strip

4301

36498

1.34

39.61

3.9

3.5

0.0

estimate

0.02

876

6823

(3021960) Folate [Moles/volume] in Serum or Plasma

1959

14659

1.43

39.33

1.5

20.4

20.7

nmol/l

0.30

1659

12704

(3022313) Gas panel - Capillary blood

558

3091

1.86

39.33

4.9

4.5

—

(3017181) Myelocytes/100 leukocytes in Blood

914

5851

1.63

38.37

4.5

4.2

0.8

0.9

0.31

257

1508

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7039

64612

1.41

37.97

5.8

5.0

39.2

38.8

mmol/mol

3.06

6538

60445

(3020630) Protein [Mass/volume] in Serum or Plasma

771

4762

1.68

37.21

2.5

66.8

66.7

g/l

0.22

705

4371

(3002179) Metamyelocytes/100 leukocytes in Blood

845

5344

1.64

37.19

4.2

4.0

0.5

0.6

0.69

196

1102

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

508

2800

1.86

36.34

5.1

4.6

24.6

mmol/l

0.19

477

2630

(3042936) Bacteria identified in Isolate by Culture

1329

9364

1.49

36.21

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

125

5.47

35.24

1.1

0.8

9.3

u/ml

1.45

101

(3025159) Blasts/100 leukocytes in Blood

832

5311

1.62

35.20

4.5

4.3

0.0

0.3

1.45

206

1185

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7474

69644

1.44

34.45

4.6

4.1

5.8

mmol/l

1.04

6907

64365

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

325

1562

2.12

34.40

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

347

1710

2.07

34.38

1.1

1.7

2.4

u/ml

0.57

430

(3003327) Ova and parasites identified in Stool by Light microscopy

508

2853

1.83

34.20

1.9

1.7

—

(3026008) Bacteria identified in Urine by Culture

2621

20982

1.35

34.16

3.2

2.8

—

(40761511) CBC panel - Blood by Automated count

8273

78788

1.63

33.74

14.9

11.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

7.42

33.45

1.0

0.1

2.1

u/ml

0.55

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

440

2395

1.88

32.71

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2824

23000

1.33

32.37

3.1

3.2

2.3

2.4

mmol/l

2.03

2417

20294

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

112

325

3.48

32.29

1.5

1.3

162.5

56.3

titre

0.48

(3004588) Protein electrophoresis panel - Serum or Plasma

633

3861

1.69

31.90

2.4

2.2

—

(3025941) Bacteria identified in Stool by Culture

713

4487

1.64

31.84

1.3

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

113

333

3.42

31.82

1.6

1.3

281.1

489.1

titre

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

216

906

2.42

31.69

1.4

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1442

10566

1.43

31.66

2.7

2.4

13.7

13.6

umol/l

0.27

1332

9851

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

212

883

2.43

31.59

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

212

885

2.43

31.43

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

211

880

2.43

31.35

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

122

381

3.23

31.32

1.7

1.4

22.4

19.5

u/ml

0.20

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

415

2248

1.89

31.31

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

212

887

2.42

31.28

1.4

1.5

—

(3018418) pH of Serum or Plasma

2450

19625

1.34

31.21

4.6

4.0

7.4

0.08

474

3806

(3024522) Salmonella sp identified in Specimen by Organism specific culture

212

888

2.42

31.20

1.4

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

2251

17813

1.35

31.06

4.2

3.9

94.3

93.2

1.34

2182

17339

(3017732) Neutrophils [#/volume] in Blood

797

5193

1.59

30.81

2.4

2.6

4.3

4.1

e9/l

1.31

623

4186

(3000570) Elastase.pancreatic [Mass/mass] in Stool

375

1976

1.94

30.76

1.3

1.4

314.7

285.2

ug/g

1.80

190

1100

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

805

5270

1.58

30.48

3.3

3.4

4.6

4.5

pmol/l

0.26

712

4722

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1196

8525

1.46

30.31

6.9

6.1

1.1

mmol/l

0.16

1120

7980

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

281

3.55

29.55

1.0

10.1

7.9

u/ml

0.22

(3044640) Blood type and Crossmatch panel - Blood

2788

22892

1.32

29.52

2.5

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

163

622

2.65

29.18

1.1

2.4

2.5

u/ml

0.02

209

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

506

2980

1.74

28.94

2.1

2.0

42.1

39.3

u/l

2.46

453

2699

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1135

8084

1.46

28.77

2.9

2.8

6.9

7.4

umol/l

0.45

978

6906

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1231

8905

1.44

28.74

2.8

2.5

23.3

23.1

0.11

1069

7688

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6102

55609

1.30

28.54

3.7

3.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1318

9677

1.42

28.33

2.7

2.4

g/l

1.29

1220

8988

(3014599) Egg white IgE Ab [Units/volume] in Serum

159

615

2.61

27.72

1.1

8.3

6.7

u/ml

0.13

175

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

466

2722

1.75

27.43

2.2

1.9

—

(3000492) Spirometry study

1027

7238

1.47

27.41

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1801

14000

1.36

27.38

1.7

1.6

34651905.2

30778118.7

pmol/l

0.10

1492

11830

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

349

1880

1.89

26.80

2.2

2.0

10.6

10.8

mg/l

0.19

319

1760

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

6.54

26.77

1.3

1.6

4.8

15.3

u/ml

0.49

(40768804) Tissue Pathology biopsy report

3519

30070

1.28

26.76

2.1

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2159

17355

1.32

25.94

2.4

2.2

—

(3022145) Colonoscopy Study observation

1089

7841

1.44

25.89

1.4

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

5.28

25.53

1.0

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

903

6308

1.48

25.09

2.5

2.3

0.2

g/l

0.55

844

5916

(3027945) Reticulocytes/100 erythrocytes in Blood

954

6754

1.46

24.74

3.1

2.8

1.7

0.10

843

6024

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1572

12171

1.35

24.16

4.1

3.4

365.0

485.3

ng/l

0.36

1043

8455

(3018001) Oat IgE Ab [Units/volume] in Serum

6.88

24.14

1.0

0.1

0.3

u/ml

1.33

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3977

34834

1.25

23.51

4.1

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

419

2485

1.72

23.36

1.9

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

721

4906

1.51

22.72

2.9

2.7

71.3

69.9

e9/l

0.50

577

3628

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1392

10669

1.36

22.70

3.1

2.8

3.8

3.3

e6/l

0.92

765

5617

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.19

22.62

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

110

392

2.83

22.56

1.1

17.3

7.2

u/ml

0.88

(3023430) Cat dander IgE Ab [Units/volume] in Serum

257

1331

1.96

22.24

1.1

5.1

5.8

u/ml

0.22

129

547

(3008898) HLA-B27 [Presence]

503

3173

1.62

22.13

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1469

11403

1.34

21.98

2.9

2.6

1.0

1.2

e6/l

1.22

841

6320

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1485

11564

1.34

21.73

2.2

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1007

7368

1.41

21.69

21.4

20.4

1.3

inr

0.34

156

1120

(3000494) Fungus identified in Specimen by Culture

1112

8277

1.39

21.67

1.6

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

302

1664

1.84

21.64

1.3

47.9

42.4

u/ml

0.21

171

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

725

4991

1.49

21.57

4.4

3.9

83.5

83.2

ng/l

0.03

630

4359

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

208

1011

2.08

21.49

1.2

1.3

0.4

0.3

nmol/l

0.26

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

272

3.15

21.09

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3241

27979

1.25

21.00

4.0

3.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

627

4219

1.52

20.80

1.1

188.0

227.9

titre

0.16

115

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

136

566

2.42

20.45

2.3

3.0

0.2

e9/l

0.28

115

472

(3014133) Dog dander IgE Ab [Units/volume] in Serum

265

1428

1.88

20.39

1.1

3.8

4.6

u/ml

0.32

129

559

(3020682) Albumin/Creatinine [Ratio] in Urine

2233

18516

1.27

20.29

4.5

4.0

13.1

10.4

mg/mmol

0.87

1418

11658

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

137

578

2.39

20.00

2.3

2.9

529.3

517.4

e6/l

0.11

114

473

(3023420) DNA double strand Ab [Units/volume] in Serum

180

852

2.14

19.96

2.0

1.6

53.9

29.6

iu/ml

—

(3009508) Creatinine [Moles/volume] in Urine

2419

20286

1.26

19.95

3.7

3.2

7.6

mmol/l

0.12

2038

17278

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

188

908

2.09

19.79

1.2

1.3

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

11.79

19.57

1.0

1.1

1.8

0.5

u/ml

0.51

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

271

1494

1.84

19.42

3.8

3.7

56.4

57.0

0.35

271

1494

(3004809) Band form neutrophils/100 leukocytes in Blood

199

989

2.04

19.40

3.6

3.4

1.1

1.5

1.04

155

777

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1605

12824

1.31

19.34

2.4

2.1

—

(4062490)

169

792

2.16

19.24

1.4

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

206

3.37

19.19

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1277

9913

1.34

18.85

2.8

2.3

29.5

29.6

0.56

1233

9602

(3048929) Epstein Barr virus Ab [Presence] in Serum

467

3009

1.58

18.80

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1310

10211

1.33

18.80

1.6

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

6.34

18.79

1.1

3.2

u/ml

0.53

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

393

2429

1.65

18.77

1.8

1.6

0.9

9.4

iu/ml

0.66

505

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

201

1017

2.00

18.66

1.3

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

130

555

2.36

18.51

1.1

1.0

0.4

1.5

u/ml

0.59

(3017354) Segmented neutrophils/100 leukocytes in Blood

136

594

2.31

18.39

3.3

58.1

56.6

0.35

384

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

128

547

2.36

18.20

2.5

2.9

806.4

754.3

e6/l

0.26

213

(3024731) MCV [Entitic volume]

8645

84383

1.65

18.06

24.1

18.1

90.4

0.31

8557

83354

(3007461) Platelets [#/volume] in Blood

8639

84316

1.65

17.97

24.2

18.1

261.2

258.8

e9/l

2.98

8501

82305

(3011412) CD3 cells [#/volume] in Blood

164

781

2.12

17.95

2.3

2.7

1.4

1.2

e9/l

1.39

473

(3026361) Erythrocytes [#/volume] in Blood

8645

84395

1.65

17.89

24.2

18.1

4.5

e12/l

1.05

8485

82212

(3010813) Leukocytes [#/volume] in Blood

8647

84421

1.65

17.87

24.2

18.1

6.9

6.7

e9/l

7.01

8490

82185

(3035941) MCH [Entitic mass]

8643

84379

1.65

17.77

24.1

18.0

30.1

0.96

8558

83351

(3008757) Leukocyte morphology finding [Identifier] in Blood

151

699

2.18

17.77

4.5

4.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

230

1240

1.88

17.72

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

166

799

2.10

17.68

1.4

1.3

0.3

0.4

g/l

2.87

122

557

(3027135) IgG subclass 1 [Mass/volume] in Serum

166

799

2.10

17.68

1.4

1.3

6.6

g/l

0.01

122

558

(3000963) Hemoglobin [Mass/volume] in Blood

8646

84423

1.65

17.67

24.3

18.2

135.1

135.0

g/l

0.20

8562

83395

(3028192) IgG subclass 2 [Mass/volume] in Serum

166

800

2.10

17.62

1.4

1.3

2.7

2.9

g/l

1.03

118

561

(3012516) Albumin [Mass/volume] in Urine

2114

17682

1.26

17.39

3.7

3.3

425.8

410.1

mg/l

0.05

1312

11039

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7536

71949

1.29

17.25

4.5

4.0

4.7

4.8

mmol/l

5.70

7038

67466

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7249

68888

1.27

17.13

4.1

3.6

1.3

mmol/l

8.31

6693

64061

(3011397) Hemoglobin [Presence] in Urine by Test strip

2018

16815

1.26

17.12

3.8

3.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2176

18292

1.25

17.08

1.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

4.88

17.05

1.1

1.0

0.2

2.0

u/ml

0.78

(3039162) Centromere protein B Ab [Units/volume] in Serum

189

967

1.98

17.04

1.3

38.6

56.1

u/ml

0.33

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

217

1165

1.88

16.96

1.1

0.4

0.5

u/ml

0.13

272

(3016031) Almond IgE Ab [Units/volume] in Serum

4.82

16.80

1.2

1.1

0.3

1.1

u/ml

1.76

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

177

891

2.01

16.72

1.2

1.3

—

nmol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

2265

19202

1.24

16.34

4.4

3.8

0.0

estimate

3.03

873

6800

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

908

6843

1.36

16.16

1.8

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

884

6634

1.37

16.16

2.7

2.4

34.2

44.9

u/l

0.79

756

5665

(3024980) IgG subclass 4 [Mass/volume] in Serum

226

1250

1.83

16.09

1.6

0.7

g/l

0.39

170

947

(3041096) Erythrocytes [Presence] in Urine by Automated

2362

20158

1.23

15.94

3.5

3.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7614

72938

1.29

15.94

4.9

4.4

2.8

mmol/l

2.52

7064

67975

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

8.71

15.88

1.2

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

4.74

15.61

1.1

5.2

7.3

u/ml

0.45

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7475

71496

1.27

15.48

4.5

3.9

1.5

mmol/l

14.60

6950

66802

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

372

2380

1.59

15.47

1.1

7.6

6.4

u/ml

0.09

326

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

331

2061

1.63

15.40

2.6

2.4

348.0

610.5

ug/l

0.91

288

1910

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

295

1792

1.67

15.13

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

904

6877

1.35

15.11

1.8

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

545

3812

1.46

14.90

1.6

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

345

2188

1.60

14.90

2.4

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

345

2188

1.60

14.90

2.4

2.2

3.6

3.8

g/l

1.10

253

1573

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

345

2190

1.60

14.84

2.4

2.2

7.3

7.4

g/l

0.68

265

1654

(44813793)

132

625

2.13

14.75

1.1

—

(3037121) Protein [Mass/volume] in Urine

365

2357

1.57

14.60

3.5

3.4

0.3

g/l

0.25

160

1033

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

645

4681

1.41

14.40

2.5

2.2

3660.0

6098.0

u/l

1.54

236

1871

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

301

1868

1.63

14.22

2.6

2.2

0.8

0.9

g/l

0.15

264

1634

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

321

2026

1.61

14.16

2.4

2.2

10.1

10.3

g/l

0.37

278

1718

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

656

4792

1.40

14.10

2.7

2.2

5.3

7.3

ug/l

1.98

549

4200

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

126

598

2.12

14.02

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

126

598

2.12

14.02

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

126

599

2.12

13.96

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

278

1700

1.66

13.93

2.6

2.0

38.1

37.9

g/l

0.20

245

1479

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

126

603

2.11

13.73

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

603

2.11

13.73

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

303

2.59

13.71

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

126

604

2.10

13.67

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

732

5478

1.37

13.57

9.1

7.9

9.0

8.8

mmol/l

0.46

701

5260

(42529406) Shigella sp [Presence] in Stool by Culture

343

2222

1.57

13.55

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

232

1362

1.72

13.55

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

432

2.31

13.54

1.6

1.5

5.3

6.2

u/l

0.92

365

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

236

1393

1.71

13.52

1.2

1.1

10.1

9.7

au/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

396

2650

1.52

13.50

2.0

1.7

1.4

1.5

g/l

0.58

337

2267

(21494815) CD4 cells/100 lymphocytes in Specimen

134

661

2.04

13.48

2.1

2.6

46.2

42.5

0.40

(3014765) Yersinia sp identified in Stool by Organism specific culture

341

2210

1.56

13.45

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

216

1246

1.75

13.43

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

338

2190

1.56

13.35

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

127

618

2.07

13.26

1.2

1.1

104.8

36.0

u/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

233

1382

1.70

13.12

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

233

1382

1.70

13.12

1.3

—

(3003396) Base excess in Arterial blood by calculation

868

6702

1.33

13.07

7.6

7.2

1.2

1.0

mmol/l

0.77

689

5210

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

322

2075

1.57

13.03

2.5

2.2

3.0

3.1

g/l

0.84

256

1622

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

354

2.41

12.93

1.8

2.6

27.4

27.5

0.03

339

(3045424) Erythrocytes [Presence] in Urine

211

1225

1.74

12.84

1.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

770

5857

1.34

12.83

6.0

4.5

5.8

kpa

0.25

752

5689

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

6.38

12.81

1.0

1.1

0.1

u/ml

—

(3016502) Oxygen saturation in Arterial blood

776

5917

1.34

12.72

8.0

7.7

95.8

95.9

0.03

744

5696

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

304

1947

1.58

12.65

1.5

486.5

495.3

mg/l

0.09

285

1847

(3019060) Gas panel - Arterial blood

525

3762

1.42

12.61

5.0

4.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

253

1551

1.65

12.59

1.9

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

503

3580

1.43

12.54

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

267

1662

1.63

12.51

2.6

2.1

0.0

g/l

2.20

250

1537

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

149

788

1.91

12.32

2.0

2.1

15.1

24.9

mg/l

3.30

209

(3052851) Hemolysis interference index of Serum or Plasma

311

2019

1.56

12.21

3.5

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

192

1102

1.76

12.19

1.9

1.7

—

(3007542) Rye IgE Ab [Units/volume] in Serum

5.11

12.19

1.1

1.0

0.3

0.8

u/ml

0.29

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

110

526

2.10

12.07

2.1

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

110

526

2.10

12.07

2.0

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

110

526

2.10

12.07

2.0

1.7

—

(40761535) Cells panel - Urine sediment

701

5313

1.35

11.96

3.9

3.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

163

896

1.83

11.96

1.2

1.1

2.3

2.4

iu/ml

—

(3013637) Mi-2 Ab [Presence] in Serum

150

3.14

11.88

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

150

3.14

11.88

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

150

3.14

11.88

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

150

3.14

11.88

1.1

—

(3002032) Base excess in Venous blood by calculation

759

5833

1.33

11.78

6.0

4.6

2.0

1.8

mmol/l

0.34

613

4731

(3044889) 12 lead EKG panel

5176

48266

1.17

11.73

3.6

3.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

246

1531

1.62

11.56

2.7

2.1

0.0

g/l

0.50

230

1412

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

318

2.40

11.49

2.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

318

2.40

11.49

2.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

318

2.40

11.49

2.3

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1214

9946

1.26

11.46

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

856

6716

1.30

11.45

7.6

7.2

5.0

5.1

kpa

1.72

813

6416

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

319

2.39

11.42

2.3

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

119

599

2.00

11.39

1.9

2.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

855

6714

1.30

11.36

7.6

7.2

12.2

12.8

kpa

2.88

812

6412

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

124

636

1.96

11.26

1.9

2.4

12.9

0.01

338

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1200

9837

1.25

11.25

1.7

1.4

0.29

1056

8788

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

260

1652

1.59

11.23

1.6

1.4

—

(3021788) Differential panel - Synovial fluid

194

1148

1.71

11.09

1.8

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1412

11803

1.23

11.08

2.9

2.8

2.4

mmol/l

1.72

1221

10280

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

241

1509

1.61

11.07

2.7

2.1

0.0

g/l

0.00

229

1408

(1175426) CD3 cells/100 lymphocytes in Blood

125

647

1.95

11.06

1.9

2.4

74.1

72.9

0.39

120

623

(3000060) B lymphocytes [#/volume] in Blood

294

2.43

11.00

1.9

2.8

199.4

261.6

e6/l

1.02

166

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

116

587

1.99

10.96

1.2

1.3

2.1

1.9

mmol/l

0.41

105

546

(3014111) Lactate [Moles/volume] in Serum or Plasma

705

5424

1.33

10.86

7.8

7.1

1.3

mmol/l

0.04

673

5213

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

623

4714

1.35

10.75

3.5

2.8

169.6

166.0

ng/l

0.08

556

4263

(3015235) Bicarbonate [Moles/volume] in Capillary blood

244

1547

1.59

10.66

3.4

3.6

24.6

24.7

mmol/l

0.17

213

1368

(3000991) Gas panel - Venous blood

700

5395

1.32

10.65

10.1

8.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1766

15151

1.21

10.64

1.6

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

375

2.22

10.55

2.0

2.8

11.5

0.01

356

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

308

2062

1.51

10.55

1.9

4.3

4.5

iu/l

0.13

100

796

(3044290) Cell count panel - Cerebral spinal fluid

251

1608

1.58

10.50

1.5

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

282

1855

1.54

10.49

2.8

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

248

1589

1.58

10.37

1.4

22.3

25.3

u/l

0.78

202

1322

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

275

1806

1.54

10.31

1.4

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

5.13

10.29

1.0

0.2

1.3

u/ml

0.67

(3002385) Erythrocyte distribution width [Ratio]

6678

63842

1.18

10.18

18.8

15.0

13.6

2.11

6568

62546

(3023511) Choriogonadotropin [Units/volume] in Urine

349

2422

1.46

10.02

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

135

743

1.83

9.95

2.0

1.7

—

(3002256) Pathology report gross observation

1122

9257

1.24

9.87

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

2.6

4.1

mg/l

0.67

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

0.8

1.7

mg/l

0.83

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

0.4

1.3

mg/l

2.01

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

1.3

2.5

mg/l

0.85

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

1.7

mg/l

0.01

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

2.7

2.4

mg/l

0.07

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.71

9.84

1.7

1.6

1.3

3.8

mg/l

2.03

(3037756) Immunofixation for Serum or Plasma

181

1088

1.68

9.81

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.61

9.78

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

605

4632

1.33

9.65

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

7343

70871

1.20

9.60

16.8

13.2

39.9

39.8

0.37

5543

54759

(3014576) Chloride [Moles/volume] in Serum or Plasma

933

7562

1.26

9.60

7.7

7.0

104.4

104.5

mmol/l

0.15

910

7420

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2089

18340

1.18

9.59

1.7

1.6

1.4

mmol/l

1.56

1768

15671

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

213

1349

1.59

9.40

1.8

1.6

—

(3028433) Virus identified in Specimen by Culture

242

2.45

9.39

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.58

9.35

1.7

0.8

2.2

mg/l

1.85

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.68

9.26

1.1

0.0

0.1

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

121

659

1.85

9.25

2.1

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

107

562

1.91

9.15

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

107

565

1.90

9.01

1.4

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

233

1524

1.54

8.96

2.0

1.7

—

(3045414) Leukocytes [Presence] in Urine

445

3291

1.37

8.93

1.7

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

396

2.08

8.89

1.9

2.1

2.0

1.9

umol/l

0.65

376

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

325

2280

1.44

8.86

4.1

3.2

3.4

3.5

g/l

0.75

308

2156

(3025296) Carrot IgE Ab [Units/volume] in Serum

8.01

8.86

1.2

1.0

0.5

4.3

u/ml

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

219

2.47

8.83

3.0

3.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

315

2199

1.45

8.81

2.2

2.0

1.3

2.1

ug/l

1.10

269

1959

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

225

1466

1.55

8.81

5.1

6.0

1005.2

830.5

iu/ml

0.12

199

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

257

1725

1.50

8.77

1.5

3.6

3.7

mmol/l

0.60

241

1614

(3002173) Hemoglobin [Mass/volume] in Arterial blood

696

5503

1.29

8.76

8.6

8.0

123.1

121.7

g/l

1.01

666

5298

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

432

3191

1.37

8.74

1.9

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

225

1469

1.55

8.73

2.3

2.4

8.0

6.5

umol/l

0.36

171

1088

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

108

579

1.88

8.70

1.3

120.9

192.0

titre

0.55

120

(3000475) Leukocytes [#/volume] in Synovial fluid

227

1492

1.53

8.56

1.8

1.6

13753.8

10836.7

e6/l

0.20

162

1080

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.61

8.54

1.3

1.2

—

(3036489) Thrombin time

390

2846

1.39

8.51

3.0

2.5

21.7

21.3

0.61

330

2437

(3021901) Oxygen saturation in Capillary blood

175

1086

1.62

8.44

2.9

3.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

111

607

1.84

8.42

1.1

9.8

9.0

iu/ml

0.09

150

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

107

579

1.86

8.39

1.3

211.3

76.5

titre

—

(3024354) Oxygen [Partial pressure] in Venous blood

624

4896

1.30

8.34

5.5

4.0

4.8

4.7

kpa

0.37

608

4742

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

125

711

1.77

8.33

1.2

98.8

63.8

u/l

0.43

487

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

129

741

1.75

8.32

3.2

3.1

5.6

12.2

nmol/l

0.41

121

720

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

133

771

1.74

8.30

1.8

1.6

51.7

54.7

0.35

481

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

965

7979

1.23

8.28

6.9

6.0

—

(3019150) Specific gravity of Urine by Refractometry

1784

15636

1.18

8.19

4.1

3.8

1.0

kg/l

0.08

268

2341

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

252

1711

1.49

8.16

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

108

594

1.83

8.06

1.2

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

6.51

8.06

1.0

0.0

0.1

u/ml

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

435

3260

1.35

8.05

3.0

2.5

0.2

0.3

e6/l

0.61

420

3150

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

109

3.04

7.98

1.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

791

6425

1.25

7.97

4.3

3.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

170

1064

1.61

7.95

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

469

1.93

7.94

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

122

700

1.75

7.92

1.3

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

316

2254

1.42

7.90

3.5

2.9

180.0

180.7

0.05

294

2151

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.43

7.88

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

123

711

1.74

7.79

2.9

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

175

1109

1.59

7.78

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

102

560

1.83

7.68

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

295

2090

1.43

7.67

1.4

1.3

212.3

127.8

titre

0.50

197

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

145

881

1.66

7.65

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

297

2108

1.42

7.65

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

250

1718

1.47

7.65

1.4

1.3

253.0

261.3

u/ml

0.18

157

1065

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

254

2.25

7.61

2.5

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

198

1301

1.53

7.53

1.3

—

(4094501)

253

1751

1.46

7.47

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

250

2.25

7.45

2.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

250

2.25

7.45

2.6

2.0

—

(3049717) Cytology report of Urine Cyto stain

263

1836

1.45

7.42

2.5

2.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

250

1729

1.46

7.41

1.6

1111.7

3500.6

e6/l

0.54

217

1387

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

231

1573

1.48

7.41

1.6

1.5

106.8

112.4

u/ml

0.19

317

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

448

3417

1.33

7.39

1.1

2.0

10.7

u/ml

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

13.35

7.37

1.2

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

262

1831

1.44

7.36

6.5

4.9

9.0

8.8

kpa

0.71

244

1727

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

249

1728

1.45

7.26

1.5

1.6

14.1

25.6

e6/l

0.81

199

1312

(3026389) Candida sp identified in Specimen by Organism specific culture

177

1149

1.55

7.13

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

670

5416

1.26

7.06

4.0

3.7

1.2

mmol/l

1.12

570

4732

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

813

6717

1.23

7.02

3.6

3.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

193

1282

1.52

7.01

1.1

2.8

3.2

u/ml

0.20

640

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

277

2.14

6.97

2.1

2.3

9.2

9.7

mg/l

0.23

238

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

439

3368

1.32

6.97

7.7

5.2

24.2

24.1

mmol/l

0.17

407

3069

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

102

2.95

6.94

1.0

1.3

—

(40765096) Chromosome analysis panel by Banding

189

2.39

6.91

1.2

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

1134

1.54

6.90

3.9

3.6

937.6

978.7

u/ml

0.03

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

187

1245

1.51

6.74

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

409

3123

1.32

6.72

9.4

24.4

24.3

mmol/l

0.35

378

2932

(3034770) Mitochondria Ab [Titer] in Serum

287

2074

1.40

6.72

1.3

1831.3

945.1

titre

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

176

1158

1.53

6.70

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

465

3616

1.30

6.70

7.3

6.7

24.7

24.5

mmol/l

0.53

436

3366

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

438

3379

1.31

6.69

2.4

2.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

130

802

1.63

6.53

3.6

4.8

117.8

78.4

u/ml

0.44

242

(3004716) Salmonella sp identified in Stool by Organism specific culture

567

4539

1.27

6.50

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

322

2388

1.36

6.45

5.9

5.1

0.9

0.19

298

2234

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

186

1250

1.50

6.43

1.3

1.2

3.9

4.3

u/ml

0.10

404

(3035637) Corticotropin [Mass/volume] in Plasma

158

1033

1.54

6.22

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

118

721

1.65

6.18

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

180

1213

1.49

6.16

1.3

1.2

3.3

4.2

u/ml

0.70

511

(3042631) Mycobacterium sp identified in Specimen

122

753

1.63

6.14

2.9

2.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

262

1897

1.39

6.10

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

355

1.92

6.07

1.1

1.3

273.1

305.0

u/l

0.12

327

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

398

1.87

6.04

1.4

1.3

—

(4015189)

146

2.47

6.00

2.1

2.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

568

1.72

5.97

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

232

1652

1.42

5.96

4.0

3.1

34.6

1.8

ratio

0.49

154

(3011985) Renin [Units/volume] in Plasma

145

940

1.55

5.95

1.8

1.6

38.2

54.0

mu/l

1.69

132

842

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

180

1222

1.48

5.95

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

321

2412

1.34

5.93

5.9

5.0

1.7

0.02

295

2252

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

387

1.87

5.90

1.4

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

402

1.85

5.87

1.2

25.0

21.1

u/l

0.22

344

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

135

865

1.57

5.84

1.1

—

73.0

—

(3032057) Clostridioides difficile [Presence] in Stool

136

2.51

5.84

1.9

2.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

117

725

1.62

5.82

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

137

882

1.56

5.81

1.1

—

2.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.51

5.80

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

412

3219

1.29

5.77

11.1

9.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

782

6566

1.21

5.77

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

127

805

1.59

5.76

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

413

1.82

5.71

1.2

98.0

84.6

u/l

0.26

362

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

236

1703

1.40

5.64

4.1

3.2

31.6

51.7

mg/l

1.55

190

1371

(3034860) Kappa light chains.free [Mass/volume] in Serum

236

1704

1.40

5.62

4.1

3.2

53.0

84.7

mg/l

0.45

190

1370

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

325

2473

1.33

5.54

4.0

2.9

95.3

93.0

1.10

298

2297

(4268621)

129

832

1.56

5.45

2.4

2.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

224

2.10

5.43

2.0

1.8

110.4

131.2

au/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

430

1.77

5.32

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

134

877

1.54

5.32

1.3

1.4

334.1

341.2

pmol/l

0.06

107

686

(3006184) Hemoglobin [Mass/volume] in Capillary blood

203

1444

1.42

5.29

2.0

2.1

134.3

129.8

g/l

1.68

139

1054

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.98

5.24

3.4

4.1

—

(3047181) Lactate [Moles/volume] in Blood

260

1935

1.35

5.17

6.5

5.8

1.3

mmol/l

0.02

233

1694

(3029075) Extractable nuclear Ab panel - Serum

222

2.08

5.16

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

305

1.91

5.13

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

305

1.91

5.13

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

115

734

1.57

5.12

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

174

1213

1.44

5.09

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

407

1.78

5.07

2.7

44.9

40.4

0.83

140

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

130

855

1.53

5.07

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

121

785

1.55

5.02

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

178

1250

1.43

5.01

1.1

—

(4024509)

105

661

1.60

4.96

1.6

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

418

1.75

4.94

2.2

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

525

4307

1.23

4.91

10.1

7.9

24.8

24.7

mmol/l

0.12

518

4282

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.86

4.91

3.4

4.0

26.0

21.0

mg/l

0.55

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1124

1.45

4.87

1.4

—

(4035726)

704

5953

1.20

4.85

1.4

—

(21494434) Karyotype in Bone marrow

506

1.67

4.75

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

499

1.67

4.73

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

190

2.11

4.71

1.4

9.6

9.0

ug/l

0.27

190

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

564

1.62

4.61

1.3

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

347

2737

1.28

4.59

3.7

3.4

25.5

25.2

mmol/l

0.73

341

2647

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

496

1.66

4.58

2.4

2.7

102.0

98.6

0.48

461

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

504

1.65

4.57

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1476

13269

1.13

4.56

4.8

4.4

2.0

2.5

ug/l

2.40

1337

11973

(1616796) Gas panel - Central venous blood

200

1459

1.38

4.56

3.8

3.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

2.14

4.54

3.8

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

2.14

4.54

3.7

3.2

—

(3044941) Cell count panel - Synovial fluid

143

984

1.46

4.52

1.6

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

186

1343

1.39

4.51

2.3

2.4

17.1

16.5

1.30

106

678

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

591

1.60

4.51

1.3

1.1

285.4

291.6

mg/l

0.29

535

(3009214) Lutropin [Units/volume] in Serum or Plasma

353

2800

1.27

4.47

1.5

1.4

10.2

10.0

u/l

0.09

301

2251

(3023323) Follitropin [Units/volume] in Serum or Plasma

617

5196

1.20

4.46

1.4

25.0

27.0

iu/l

0.90

552

4432

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

577

1.60

4.46

2.7

2.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

439

1.69

4.45

1.1

1.0

8.6

nmol/l

1.27

(1761482) Bacteria [#/volume] in Urine by Culture

199

1458

1.37

4.43

3.8

4.0

—

(3039000) Anion gap in Blood

186

1348

1.39

4.42

8.0

6.8

11.1

11.3

mmol/l

0.36

164

1205

(3018572) Chloride [Moles/volume] in Blood

186

1349

1.39

4.41

8.0

6.8

104.7

105.3

mmol/l

1.00

164

1206

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

301

1.83

4.36

1.2

1.1

103.6

109.2

0.50

275

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

183

2.08

4.34

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

217

1.99

4.34

1.1

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.88

4.32

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

126

856

1.48

4.27

1.4

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

178

1290

1.39

4.25

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

633

1.55

4.21

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

103

674

1.53

4.18

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

181

1320

1.38

4.17

3.3

3.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

2.09

4.15

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

173

2.09

4.15

1.1

—

205.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

137

954

1.44

4.11

1.7

1.6

—

(3051651) Icteric interference index of Serum or Plasma

419

1.68

4.11

5.1

3.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

880

1.46

4.11

1.4

—

(3002619) Bacteria identified in Specimen by Culture

141

2.20

4.10

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

293

1.81

4.09

1.1

93.2

91.1

0.26

122

(3021387) Prolactin [Units/volume] in Serum or Plasma

447

3681

1.23

4.09

1.6

297.8

309.5

mu/l

0.23

410

3306

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

731

6298

1.17

4.09

3.4

3.9

16.7

28.8

ug/l

0.81

578

4934

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

520

1.60

4.08

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

528

1.60

4.07

1.2

1.1

ratio

0.52

185

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

615

1.55

4.06

1.1

—

(44790049)

116

784

1.49

4.06

1.6

—

(44790047)

116

784

1.49

4.06

1.6

—

(44806118)

116

784

1.49

4.06

1.6

—

(44790048)

116

784

1.49

4.06

1.6

—

(3011288) Drugs identified in Urine by Screen method

347

2782

1.26

4.05

3.5

3.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

175

1276

1.38

4.05

4.2

3.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

553

1.58

4.03

1.0

—

(3044927) Protein electrophoresis panel - Urine

553

1.58

4.03

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

429

1.66

4.03

1.6

1.5

5.9

4.8

u/l

0.22

212

(3017446) Testosterone [Moles/volume] in Serum or Plasma

513

4297

1.21

3.96

2.4

2.1

10.5

11.8

nmol/l

3.54

453

3796

(3045142) Bone marrow Pathology biopsy report

103

684

1.51

3.93

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

276

1.82

3.90

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

163

1183

1.38

3.90

1.2

1.1

121.2

117.2

0.83

142

1070

(3051611) Lipemic interference index of Serum or Plasma

102

678

1.51

3.88

4.4

3.2

—

(40768441) Liver Pathology biopsy report

543

1.57

3.87

1.1

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.50

3.87

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

292

1.79

3.84

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

134

944

1.43

3.81

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

444

1.63

3.80

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

414

1.65

3.77

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

8.76

3.77

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

194

1.96

3.76

1.1

104.4

79.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

386

3161

1.23

3.75

2.8

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

430

1.63

3.75

1.2

1.1

2.9

14.6

u/ml

0.73

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

287

1.78

3.75

1.1

1.2

90.2

90.7

0.04

124

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

444

3690

1.21

3.74

9.7

9.0

1.3

1.4

0.23

439

3668

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

104

701

1.49

3.72

1.1

273.4

241.1

mg/l

0.51

615

(4306422)

168

1237

1.36

3.70

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

161

2.05

3.69

1.8

1.6

0.4

ug/l

0.28

106

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1741

15989

1.11

3.69

1.6

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

198

1497

1.33

3.67

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

198

1497

1.33

3.67

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

256

2005

1.28

3.66

6.9

5.9

1.4

mg/l

0.16

239

1876

(3030313) Adrenal Ab [Titer] in Serum

103

2.33

3.65

1.2

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

312

1.74

3.64

2.3

2.9

99.0

145.4

au/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.54

3.62

3.3

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

397

1.64

3.58

1.4

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

315

1.72

3.53

1.4

1.5

3.9

3.2

0.10

(3051593) INR in Capillary blood by Coagulation assay

227

1.85

3.53

7.4

9.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

164

1214

1.36

3.51

1.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

105

719

1.47

3.50

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

339

1.69

3.48

1.2

1.1

28.5

20.0

u/l

0.57

256

(3035320) C reactive protein [Mass/volume] in Body fluid

542

1.54

3.47

1.8

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

243

1.81

3.46

2.1

2.4

—

(1002224) Polysomnography panel

395

3272

1.22

3.46

1.1

—

(3045716) Anion gap in Serum or Plasma

258

1.79

3.45

2.1

2.3

8.5

9.2

mmol/l

0.77

202

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

194

1.91

3.42

1.1

79.4

68.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

105

723

1.46

3.41

1.2

46.4

38.4

mg/l

0.78

612

(40768446) Kidney Pathology biopsy report

296

1.73

3.41

1.6

1.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

342

1.67

3.38

1.2

1.1

97.2

76.6

u/l

1.09

269

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

546

1.52

3.37

3.8

4.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

162

1206

1.35

3.36

1.1

5567.3

7951.7

iu/ml

0.10

307

(21494890) Protein electrophoresis panel - 24 hour Urine

547

1.52

3.34

2.4

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

261

1.77

3.33

1.5

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.92

3.29

1.4

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1168

10559

1.12

3.28

4.0

3.9

21.5

21.6

0.08

540

4708

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1043

9367

1.13

3.28

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

327

2677

1.23

3.24

4.6

3.3

0.7

0.82

314

2567

(3036603) Volume of Urine

424

1.58

3.24

1.5

1867.8

2078.5

0.55

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

440

1.57

3.23

1.6

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

552

1.51

3.22

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

119

849

1.41

3.21

1.2

1.1

95.0

95.1

0.01

106

803

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

3.20

1.3

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.50

3.20

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

117

2.14

3.15

1.2

1.1

—

(4146454)

621

1.47

3.13

2.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

111

2.17

3.11

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

125

2.08

3.07

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

527

4536

1.17

3.05

2.9

3.2

45.6

47.9

u/ml

0.09

499

4379

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

262

2109

1.25

3.05

2.8

3.5

160.6

2605.9

u/ml

1.14

218

1799

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

174

1.90

3.03

1.2

383.9

306.6

pmol/l

0.48

127

(3048879) Bone marrow aspiration report

147

1.98

2.98

1.3

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

168

1.91

2.98

2.2

1.8

16.0

50.5

u/l

1.52

156

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

587

1.47

2.97

1.7

1.5

35.0

34.2

0.07

357

(3019174) dRVVT (LA screen)

2.40

2.96

1.1

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

189

1468

1.29

2.96

4.2

4.0

5.1

5.0

kpa

0.58

182

1446

(3012501) Base excess in Blood by calculation

189

1468

1.29

2.96

4.2

4.0

2.6

2.4

mmol/l

0.42

121

958

(37021550) Renin [Units/volume] in Plasma --upright

162

1.92

2.93

1.3

60.4

113.1

mu/l

0.56

129

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

333

1.63

2.93

2.9

3.5

7.9

8.4

mg/l

0.23

261

(3015183) Erythrocyte sedimentation rate

445

1.53

2.88

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

327

1.62

2.88

1.8

2.0

75.7

157.7

umol/l

2.68

174

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

382

1.57

2.87

1.3

1.2

—

(3019977) pH of Arterial blood

312

1.64

2.86

3.2

3.0

7.4

0.04

107

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

312

1.64

2.86

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

297

1.65

2.85

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

189

1476

1.29

2.85

4.0

9.0

8.8

kpa

1.05

182

1453

(3033923) Metanephrine [Moles/time] in 24 hour Urine

129

2.02

2.85

1.1

0.6

0.7

umol/24h

0.54

(3028707) Methadone [Presence] in Urine by Screen method

224

1787

1.26

2.84

3.2

2.9

—

(3020393) Adenovirus Ag [Presence] in Stool

136

1.99

2.84

2.1

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

686

1.42

2.80

1.4

—

titre

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

554

1.47

2.79

1.7

1.3

1.5

nmol/l

0.53

498

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

2.79

1.6

1.4

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.45

2.79

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

299

1.64

2.79

1.1

71.8

334.0

ng/l

1.45

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

354

1.59

2.77

1.8

1.6

3.4

3.3

u/field

0.03

249

(3028271) Lactate [Moles/volume] in Capillary blood

135

1012

1.34

2.75

2.0

1.9

1.6

1.7

mmol/l

0.20

130

987

(3047189) Immunofixation for 24 hour Urine

247

1.70

2.74

1.8

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

961

1.35

2.74

1.1

1.5

g/l

0.17

116

866

(44806071)

111

2.07

2.72

1.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

215

1718

1.26

2.71

4.2

4.0

3.8

mmol/l

0.69

199

1621

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

231

1862

1.25

2.70

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

195

1541

1.27

2.70

1.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

288

1.64

2.65

1.4

1.5

15.9

14.7

pmol/l

0.18

243

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.79

2.64

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

140

1.93

2.64

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

375

1.55

2.62

1.5

1.6

1.5

4.7

nmol/l

1.64

301

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

855

7698

1.12

2.61

2.8

0.7

ug/l

0.02

557

4807

(3010421) pH of Blood

214

1718

1.25

2.61

4.2

3.8

7.4

0.05

182

1446

(3005011) Chlamydia sp Ab [Titer] in Serum

134

1.94

2.59

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

230

1863

1.24

2.59

5.3

3.9

0.4

0.3

u/ml

0.76

142

1046

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.60

2.57

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.22

2.53

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

208

1.73

2.53

1.1

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.03

2.52

5.5

6.0

—

(3003181) Sodium [Moles/volume] in Urine

141

1079

1.31

2.52

1.5

1.4

65.8

64.7

mmol/l

0.10

119

866

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

101

2.08

2.52

1.1

1.4

22.7

75.9

ng/l

1.35

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

186

1.78

2.52

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.16

2.50

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

194

1.76

2.49

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.14

2.44

1.3

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

414

3567

1.17

2.43

5.0

3.6

130.1

129.7

g/l

0.11

404

3479

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

647

1.39

2.42

1.1

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

204

1.72

2.40

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.34

2.39

4.8

5.6

362.9

453.1

umol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

516

1.44

2.36

2.5

1.9

0.4

1.4

g/24h

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

226

1851

1.23

2.33

1.9

1.7

42.2

41.7

nmol/l

0.07

217

1800

(3023410) Appearance of Cerebral spinal fluid

112

841

1.34

2.31

1.9

2.0

—

(3052592) Norovirus Ag [Presence] in Stool

119

1.94

2.29

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

159

1255

1.27

2.28

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

378

3255

1.17

2.26

1.7

4.2

3.7

mg/l

0.40

290

2249

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

123

940

1.31

2.26

1.3

1.2

32.5

36.1

u/l

0.08

110

812

(3004451) EKG impression Narrative

270

1.60

2.25

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

278

1.59

2.24

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

279

1.58

2.21

7.1

4.7

60.8

66.4

mg/l

0.34

210

(3016879) Cocaine [Presence] in Urine

435

3795

1.15

2.20

2.6

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1191

11012

1.09

2.20

1.6

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

203

1.68

2.16

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

380

3287

1.16

2.16

1.4

1.3

258.1

228.0

miu/ml

0.83

177

1580

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

215

1769

1.22

2.15

1.3

1.2

—

(3016135) IgD [Mass/volume] in Serum

4.29

2.15

1.2

48.8

73.4

mg/l

—

(21494755) Public health laboratory ask at order entry panel

808

8880

0.90

2.14

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

469

1.43

2.13

1.8

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

128

993

1.29

2.13

1.8

1.7

2000.0

1751.4

titre

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

323

2765

1.17

2.10

1.4

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

299

1.54

2.10

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

375

3249

1.16

2.10

3.4

3.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

439

1.44

2.06

1.3

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.50

2.05

1.1

1.3

—

(40768795) Lymph node Pathology biopsy report

694

1.34

2.04

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

350

1.49

2.03

21.2

28.5

130.5

119.6

ug/l

0.32

295

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

153

1222

1.26

2.03

2.2

1.9

176.6

189.1

pmol/l

0.83

142

1151

(3028300) Cannabinoids [Presence] in Urine

470

4152

1.14

2.01

2.6

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

500

1.40

2.01

5.8

6.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

166

1340

1.24

2.01

2.8

2.9

34.3

34.8

umol/l

0.09

137

1159

(3027008) Opiates [Presence] in Urine

469

4143

1.14

2.01

2.5

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

602

1.37

2.00

1.4

1.3

5.7

5.3

umol/l

0.36

560

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

185

1.68

2.00

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

637

1.35

1.99

1.8

2.1

19.0

24.3

ug/l

0.97

627

(3040893) Potassium [Moles/volume] in Capillary blood

3.34

1.96

5.4

3.0

4.2

4.5

mmol/l

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

777

1.32

1.96

6.1

6.8

11.2

11.3

mg/l

0.02

723

(3000764) Benzodiazepines [Presence] in Urine

465

4113

1.14

1.96

2.6

2.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

149

1.75

1.94

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.96

1.93

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

488

1.40

1.92

1.1

u/l

0.18

211

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.05

1.90

3.3

4.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

307

1.50

1.89

1.9

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

307

1.50

1.89

1.9

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

601

5414

1.12

1.89

2.6

2.5

69.1

70.7

ml/min/173m2

0.46

230

2065

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

1254

1.24

1.86

3.1

3.4

109.1

588.8

u/ml

1.48

133

1141

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

120

1518

0.79

1.86

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

379

3322

1.15

1.85

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

367

1.45

1.83

1.9

1.7

1.3

nmol/l

0.03

289

(3033705) Calcium.ionized [Moles/volume] in Venous blood

631

1.33

1.80

2.5

2.3

—

(3020891) Body temperature

273

2341

1.17

1.79

4.9

4.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

563

1.35

1.79

1.5

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

320

1.47

1.77

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

370

1.43

1.76

1.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.67

1.72

2.9

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

100

1278

0.78

1.71

2.0

2.4

13.2

13.1

0.10

100

1261

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.13

1.71

1.1

—

(3004775) Volume in Urine collected for unspecified duration

443

1.38

1.65

2.1

2.2

562.7

633.2

0.98

307

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

260

1.50

1.65

3.7

4.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

204

1.57

1.64

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

142

1.69

1.64

2.3

2.4

—

(3000012) Reticulocyte production index

318

1.45

1.63

1.7

1.5

—

(3022621) pH of Urine by Test strip

519

4683

1.11

1.62

2.9

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.57

1.61

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

847

7835

1.09

1.60

2.1

1.9

—

(40758358) Immune stain study

2.50

1.59

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

752

1.28

1.57

1.3

1.4

11.7

11.4

mmol/l

0.09

145

(3020491) Glucose [Moles/volume] in Blood

568

1.32

1.57

1.6

1.8

6.6

6.3

mmol/l

0.45

421

(21494814) CD8 cells/100 lymphocytes in Specimen

288

1.46

1.56

2.0

2.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

280

1.47

1.56

4.8

3.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

152

1.65

1.56

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

674

6184

1.10

1.53

1.9

1.8

—

(40768793) Breast Pathology biopsy report

219

1873

1.17

1.53

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

649

1.30

1.53

2.5

2.3

106.3

105.3

mmol/l

1.37

640

(3041354) Potassium [Moles/volume] in Venous blood

650

1.30

1.51

2.5

2.3

4.0

mmol/l

0.07

641

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

163

1360

1.20

1.51

2.4

93.7

101.3

ug/min

0.08

845

(3016750) Collection duration of Urine

332

1.42

1.51

2.1

2.2

531.9

498.3

min

1.58

257

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.51

0.0

1.6

—

0.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

563

1.32

1.51

1.7

1.4

129399.0

78223.3

e6/l

0.26

395

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

392

1.38

1.49

1.1

97.8

92.1

0.58

312

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

166

1390

1.20

1.49

2.9

2.2

0.8

nmol/l

0.13

132

1189

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

202

1.54

1.47

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.43

1.47

2.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.43

1.47

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

259

1.47

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

884

1.25

1.47

3.1

0.7

0.8

nmol/l

1.47

673

(3023199) Leukocytes [#/volume] in Pleural fluid

593

1.30

1.45

1.7

1.5

1876.0

2140.5

e6/l

0.30

439

(3001019) Free T4 and TSH panel - Serum or Plasma

552

5035

1.10

1.43

1.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.73

1.43

1.2

1.4

1.5

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.31

1.42

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

164

1.59

1.42

1.4

1.2

44.5

38.1

g/l

1.64

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

110

1.73

1.42

1.5

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

328

1.40

1.42

2.1

2.4

58.4

52.3

umol/l

0.62

280

(3020191) Ethanol [Moles/volume] in Serum or Plasma

604

1.29

1.42

1.4

1.3

promille

0.10

466

(3006653) Thiamine [Moles/volume] in Blood

345

1.39

1.41

1.2

1.4

134.6

131.9

nmol/l

0.17

345

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.82

1.41

6.7

11.3

6.5

5.5

mmol/l

0.55

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

103

1.75

1.40

2.4

2.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

213

1.50

1.40

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.25

1.40

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

423

1.35

1.39

1.1

1384.6

1534.8

miu/ml

0.47

423

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.94

1.38

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

776

1.25

1.37

2.9

2.5

18.9

20.1

nmol/l

0.67

746

(3037556) Urate [Mass/volume] in Serum or Plasma

174

1.55

1.36

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

272

1.44

1.36

1.6

1.2

—

(3027944) Amphetamines [Presence] in Urine

451

4086

1.11

1.35

2.3

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

256

1.45

1.35

1.4

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

123

1012

1.22

1.35

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

273

1.43

1.34

2.1

2.5

—

(3018133) Calcium [Moles/volume] in Urine

175

1.54

1.34

1.8

2.6

3.4

2.6

mmol/l

0.77

159

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

663

1.27

1.33

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

324

1.39

1.33

2.7

3.0

1.2

1.4

ug/l

0.31

307

(3024928) Oxygen saturation in Venous blood

154

1297

1.19

1.33

6.7

4.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

128

1.64

1.32

2.3

2.2

7.7

7.2

mmol/l

0.20

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

186

1593

1.17

1.32

1.9

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

127

1052

1.21

1.31

5.0

5.4

342.0

375.1

umol/l

1.66

104

918

(3003338) MCHC [Mass/volume]

6529

66149

0.95

1.29

20.2

15.5

332.5

g/l

0.08

6495

65662

(3028308) Erythrocytes [#/volume] in Pleural fluid

525

1.30

1.29

1.6

1.5

81975.5

67382.9

e6/l

0.12

310

(4027681)

569

1.29

1.4

1.2

—

(3005033) Fetal Nuchal fold Thickness US

225

2576

0.87

1.28

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

153

1.57

1.28

1.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.08

1.27

1.0

1.3

—

(3012565) Volume of 24 hour Urine

344

1.37

1.27

1.9

2.2

2134.3

2012.8

0.28

317

(3042517) Benzodiazepines panel - Urine

115

1.65

1.24

6.3

2.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.40

1.24

1.3

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

235

2061

1.14

1.23

1.4

110.0

135.0

pmol/l

0.46

227

2006

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.86

1.23

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

187

1.50

1.23

1.2

1.1

—

(4034850)

259

2289

1.14

1.22

9.7

8.7

—

(3014051) Protein [Presence] in Urine by Test strip

192

1662

1.16

1.21

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.63

1.21

1.4

1.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.72

1.21

1.3

1.4

43.0

62.0

—

(3017704) Immunofixation for Urine

305

1.38

1.20

1.3

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

221

1.45

1.20

2.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

124

1.61

1.20

2.2

1.8

—

(3012441) Differential panel - Pleural fluid

496

1.29

1.20

1.8

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

314

1.37

1.19

1.4

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

227

2581

0.88

1.19

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

181

1.49

1.18

1.2

1.3

—

(3034426) Prothrombin time (PT)

281

1.39

1.17

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.93

1.16

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

134

1.57

1.14

2.0

2.5

1.3

1.7

mmol/l

0.22

100

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

326

1.35

1.13

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

369

3348

1.11

1.12

1.4

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

111

1.62

1.11

1.9

2.9

8.7

19.3

mg/l

—

(3040151) Glucose [Moles/volume] in Capillary blood

727

1.23

1.10

4.4

5.5

7.2

mmol/l

0.04

605

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

1.49

1.09

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

1.53

1.08

8.0

6.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

648

1.24

1.07

1.7

1.5

35.3

32.8

g/l

1.02

591

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

506

1.27

1.06

1.8

2.0

1.4

2.1

u/field

0.78

211

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

331

1.33

1.04

1.8

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

112

943

1.19

1.03

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.06

1.02

4.7

3.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.73

1.02

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.89

1.01

1.0

1.2

4.6

15.1

u/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

256

1.37

1.00

2.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

343

1.31

0.99

1.7

2.6

47.9

51.2

umol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.84

0.98

1.1

1.2

—

(3049242) von Willebrand panel - Platelet poor plasma

2.17

0.98

1.4

1.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.95

0.97

8.9

6.6

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.95

0.97

1.6

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

738

7833

0.94

0.96

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

241

1.37

0.96

5.8

4.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

238

2652

0.89

0.95

1.4

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

328

1.31

0.95

1.3

15.8

11.5

u/l

0.76

304

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

241

2682

0.90

0.94

1.9

1.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

174

1.44

0.94

1.7

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

174

1.44

0.94

1.7

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

174

1.44

0.94

1.6

1.2

—

(3008295) Osmolality of Serum or Plasma

714

1.21

0.94

1.7

1.5

280.5

280.6

mosm/kgh2o

0.01

554

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

542

1.24

0.94

1.3

2.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.89

0.94

6.0

4.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

150

1.47

0.92

1.3

1.6

—

(3014891) Appearance of Pleural fluid

1.75

0.90

2.3

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

152

1.45

0.87

9.5

7.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.79

0.87

1.1

1.3

7.4

5.8

mmol/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

103

1.55

0.87

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.58

0.87

1.4

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.58

0.87

3.4

5.7

22.6

39.5

ug/min

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.94

0.84

1.0

1.2

187.7

219.0

pmol/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

205

2282

0.90

0.84

1.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

196

1.38

0.83

2.0

2.2

11.6

17.2

umol/l

3.33

196

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

389

0.74

0.83

1.1

1.3

—

(3001556) Androgen free Index in Serum or Plasma

121

1.49

0.82

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.74

0.82

1.1

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.88

0.81

1.2

1.1

0.0

mg/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

617

1.20

0.81

1.0

1.1

—

(3013466) aPTT in Blood by Coagulation assay

1.70

0.80

1.0

36.4

36.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

139

1.44

0.79

10.2

7.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

1.41

0.78

1.4

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

377

4060

0.93

0.78

1.4

—

(3014271) Vancomycin [Susceptibility]

260

1.31

0.77

2.5

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

148

1.42

0.77

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

123

1.46

0.77

1.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

385

1.25

0.76

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.77

0.76

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

270

1.30

0.75

1.3

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

377

1.25

0.75

1.0

256.4

337.8

ng/l

2.17

259

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

378

1.24

0.74

1.0

815.8

738.4

ng/l

0.45

254

(40758292) HTLV I+II Ab panel - Serum

134

0.60

0.73

2.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

295

3196

0.92

0.72

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.62

0.71

2.1

2.4

0.8

0.7

u/field

0.20

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

296

3203

0.92

0.71

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

194

1.34

0.71

1.8

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

296

3201

0.92

0.70

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

381

1.23

0.70

1.0

39.3

45.3

ng/l

0.57

256

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.64

0.68

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.68

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

602

1.18

0.68

2.8

3.0

58.5

54.5

mg/l

0.04

443

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

295

3184

0.92

0.67

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

465

1.21

0.67

1.4

62.4

126.1

pmol/l

0.51

150

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.63

0.66

1.0

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.63

0.66

3.1

3.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

510

5394

0.94

0.66

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

169

1527

1.11

0.65

1.6

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.54

0.65

1.5

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

579

6095

0.95

0.64

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.72

0.64

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

617

1.17

0.62

1.9

1.7

—

(3024471) HLA-A [Type]

252

1.27

0.62

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.59

0.61

1.0

1.1

1.8

1.6

umol/24h

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.61

1.3

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.60

0.0

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.57

0.60

6.3

4.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.57

0.60

2.5

1.4

46.6

43.0

umol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.58

0.0

3.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.51

0.58

6.5

4.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

282

1.24

0.57

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.56

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.45

0.56

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

178

1630

1.09

0.56

1.3

3.0

3.9

ug/l

1.55

164

1471

(3025315) Body weight

1.54

0.55

4.4

3.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.54

0.55

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

440

1.18

0.54

1.2

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.58

0.54

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.41

0.54

1.7

1.3

1.6

mg/l

0.73

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

102

910

1.12

0.53

1.5

1.6

7.9

7.6

mmol/l

0.53

558

(3011325) HIV 1+2 Ab [Presence] in Serum

1.54

0.53

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.61

0.51

5.0

6.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.50

0.51

17.0

6.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

1.38

0.50

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

110

0.64

0.48

1.1

1.2

—

(4038314)

1.52

0.48

1.3

1.2

—

(3024263) Appearance of Synovial fluid

346

1.19

0.46

2.0

1.8

—

(3024932) HLA-DR beta [Type]

246

1.22

0.45

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.37

0.43

6.6

7.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

104

1.35

0.43

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.40

0.42

1.3

1.2

—

2.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.36

0.41

1.1

1.5

69.9

73.7

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.40

0.0

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.47

0.40

1.4

1.9

0.5

0.7

umol/l

—

(1761868) Lipid panel - Serum or Plasma

2816

27766

1.02

0.40

2.7

2.5

—

(44806420)

132

1.29

0.40

1.9

2.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.34

0.39

1.1

1.3

—

97.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.34

0.39

2.0

3.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

106

1.32

0.39

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

115

1.30

0.38

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

652

0.89

0.37

1.3

1.4

30.5

31.4

nmol/l

0.05

590

(3044242) Glucose [Moles/volume] in Arterial blood

271

1.18

0.37

3.2

2.1

—

(3035880) pH of Pleural fluid

262

1.18

0.36

1.5

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

1.27

0.36

1.7

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.29

0.36

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

157

0.76

0.35

4.3

3.0

1.2

mmol/l

0.33

146

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.43

0.35

1.2

1.0

8.3

mmol/l

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

162

1.24

0.35

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

470

1.13

0.35

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

518

1.12

0.34

1.6

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.34

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

167

0.78

0.34

1.6

2.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

157

1471

1.07

0.34

4.2

3.3

27.9

25.1

mg/l

0.36

896

(4211845)

396

1.14

0.33

3.2

3.0

—

(3024869) Neuronal Ab [Presence] in Serum

100

1.30

0.33

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

164

1.22

0.32

2.1

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

119

1.26

0.31

1.2

1.4

370.3

ug/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

119

1.26

0.31

1.9

1.6

147.4

111.4

ng/l

0.45

119

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

110

1.27

0.31

1.9

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

165

1.21

0.31

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

258

1.16

0.30

1.7

2.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

335

0.87

0.29

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.27

0.27

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.25

0.27

1.8

2.2

—

(3006462) Nitrate [Presence] in Urine

366

1.12

0.26

3.4

3.1

—

(3035933) Granulocytes/100 leukocytes in Blood

310

0.87

0.26

1.4

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

467

0.90

0.25

1.7

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

161

1.18

0.24

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2303

22795

1.01

0.22

1.6

—

(4198724)

467

1.09

0.22

1.3

2.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.22

0.22

1.2

1.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.19

0.21

1.2

1.6

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.21

0.0

2.8

—

11.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.6

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.21

0.0

1.0

—

164.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

334

3439

0.97

0.21

1.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.25

0.20

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

780

1.06

0.20

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

202

1.14

0.20

1.4

1.8

0.1

0.2

nmol/l

1.25

141

(3007463) Buprenorphine [Presence] in Urine

1.22

0.20

21.5

5.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.18

0.19

3.3

5.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

157

1.15

0.17

3.1

2.4

—

(3017509) Phencyclidine [Presence] in Urine

110

1.18

0.17

1.1

1.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

167

1.14

0.16

1.2

1.4

59.6

39.2

1.39

108

(3029396) Erythrocyte agglutination [Presence] in Blood

303

1.09

0.15

2.6

3.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

828

0.95

0.14

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

180

0.89

0.13

4.9

5.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

180

0.89

0.13

2.4

2.8

—

(3033799) Differential panel - Peritoneal fluid

179

0.89

0.12

1.5

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

514

1.05

0.11

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

286

2908

0.98

0.09

1.5

1.6

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.06

0.09

1.6

1.5

352.4

312.0

umol/24h

—

(3051339) Copper [Moles/volume] in Blood

1.09

0.08

1.3

1.2

16.3

17.2

umol/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

136

1.10

0.08

2.3

2.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.14

0.08

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.14

0.08

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

926

0.97

0.08

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

125

1221

1.02

0.08

1.4

6.9

7.0

mmol/l

0.15

894

(3006598) pH of Arterial cord blood

127

1.10

0.07

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.03

0.07

1.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.87

0.07

1.4

1.9

1.7

2.3

nmol/l

—

(3000285) Sodium [Moles/volume] in Blood

0.87

0.07

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.06

0.07

1.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

314

1.05

0.07

1.4

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.02

0.07

2.6

2.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

234

0.94

0.06

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

171

1682

1.02

0.06

1.4

1.5

0.4

nmol/l

0.30

131

1328

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.11

0.06

1.2

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

158

1.08

0.06

1.0

1.1

21.7

19.8

mmol/l

1.40

140

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

345

1.04

0.06

6.8

5.7

70.4

9203.0

u/ml

—

(4133840)

192

0.94

0.05

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

605

0.98

0.04

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

249

1.04

0.04

2.5

2.7

27.7

28.0

umol/l

0.04

179

(3025130) Human papilloma virus identified in Specimen

135

1368

0.99

0.04

1.8

1.7

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

139

0.94

0.03

4.2

2.8

1.2

mmol/l

0.37

129

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

310

3121

0.99

0.03

2.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

152

1.05

0.02

1.3

4.3

3.2

mmol/l

0.65

141

(4281824)

822

1.01

0.01

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

507

0.99

0.01

1.3

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

214

1.03

0.00

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

306

0.98

0.00

1.6

1.2

—

(3011648) Oxygen content in Venous blood

536

0.99

0.00

5.2

4.0

11.9

11.3

0.51

536

(3025577) Chromium [Mass/volume] in Blood

323

0.99

0.00

2.0

1.7

2.5

ug/l

1.13

275

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

116

1.03

0.00

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

414

0.99

0.00

2.0

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.00

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

305

0.98

0.00

2.2

2.0

874.3

120.1

ug/min

—

(3020650) Glucose [Presence] in Urine

218

1.01

0.00

1.1

1.4

—

(3006270) Folate [Moles/volume] in Blood

582

1.00

0.00

1.1

380.1

382.3

nmol/l

0.03

523

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

241

1.00

0.00

2.7

2.5

95.4

132.7

ng/l

0.82

134

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(4212803)

0.86

0.00

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.3

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

4.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.92

0.00

1.8

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

5.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

330

1.00

0.00

1.4

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.96

0.00

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.4

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.8

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.1

—

198.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_URTICA_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_URTICA_NAS	1.137 [1.01, 1.28]	0.03
Birth year	0.995 [0.99, 1.0]	0.225

During the follow-up period (1.1.1998 — 31.12.2019), 1906 out of 33280 females with L12_URTICA_NAS died.

Males

Parameter	HR [95% CI]	p-value
L12_URTICA_NAS	1.127 [0.99, 1.28]	0.066
Birth year	0.986 [0.97, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 1363 out of 21008 males with L12_URTICA_NAS died.

Mortality risk

Mortality risk for people of age

years, who have L12_URTICA_NAS.

N-year risk	Females	Males
1	0.082%	0.22%
5	0.602%	1.272%
10	1.525%	3.369%
15	2.983%	6.249%
20	5.724%	10.368%

Relationships between endpoints

↥

Index endpoint: L12_URTICA_NAS – Other and unspecified urticaria

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints